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Abstract 
The folate-associated one-carbon (1C) metabolic pathways provide the 
building blocks for key components of DNA (thymidylate and purines), as well as the 
supply of methyl groups for methyltransferases. The free formate pool plays an 
essential role in the transport of one-carbon units from production to utilization. An 
enzymatic assay was optimized for the determination of the plasma formate 
concentration in rats under normal and folate-deficient conditions. Stable isotope 
tracer infusions were used to quantify the endogenous production rates of formate; 
this amounted to 75 11mol/hr /100 g body weight in folate-replete rats, dropping to 
45 11mol/hr /100 g body weight in folate-deficient rats. This means that, in (healthy) 
folate-replete rats, endogenous formate production accounts for -35% of the tota l 
ingested potential 1C groups ( 44% of that remaining after accounting for net protein 
synthesis). This could indicate that formate production is a central component of 
the metabolism of some of these 1C precursors. We investigated the importance of 
known dietary 1C precursors to the 1C pool through a dietary precursor 
supplementation study. Serine, histidine, and choline were found to be significant 
precursors to formate. 
ii 
Acknowledgements 
I would like to thank my supervisors Dr. J.T. Brosnan, Dr. M.E. Brosnan, and 
Dr. S.G. Lamarre. Their guidance and mentorship has made this experience 
enriching and fulfilling. I would also like to convey my gratitude to Dr. S. Christian 
and Dr. E. Randell who served on my supervisory committee. Their expertise and 
advice was essential and greatly appreciated. Dr. David Schneider provided 
statistical advice, his time and expertise were greatly appreciated. 
Thanks are also due to the various colleagues who shared the laboratory 
during this time. They gave their time and knowledge freely and were instrumental 
in maintaining a pleasant and collegial atmosphere. 
Finally, I would like to thank the Canadian Institutes of Health Research for 
their financial support of my research, and the Memorial University School of 
Graduate Studies for a fellowship. 
iii 
Table of Contents 
Abstract ............................................................ ......................................... ...................................................... ii 
Acknowledgements .................................................................................................................................. iii 
Table of Contents ................................... ................................. .................................................................. iv 
List of Tables .......................... .................................................................................................................... vii 
List of Figures .................................................. ........................... .................. ............................................ viii 
List of Abbreviations .................................... ............. ............................................................................ xiii 
List of Appendices .......................................................... .... ..................................................................... xv 
Chapter One- Introduction ... ................................................................................................................. 1 
1.1 One-carbon metabolism .............................................................................................................. 2 
1.2 Folate ........................................................................... ........................................................................ 5 
1.3 Formate increases during folate deficiency ........................................................................ 8 
1.4 Folate-mediated one-carbon production ............................................................................. 8 
1.4.1 Serine .................. ......... ................................................................................................................ 8 
1.4.2 Glycine ........ ................ .......... .................................................................................................... 10 
1.4.3 Methionine ............................ .................................................................................................. 11 
1.4.4 Histidine ....... .......................... .... ................................................................................ .............. 13 
1.4.5 Choline ...... ................ .... .... ....................................................................... ................... .............. 13 
1.5 Folate-independent one-carbon production ........ ....................................... .................... 16 
1.5.1 Tryptophan ....... ..... ..... .... ........................................................................................................ 16 
1.5.2 Other sources of folate-independent formate ............ .......... .... ............... ................ 18 
1.6 Mitochondrial one-carbon production and utilization ............................................... 18 
1.7 Cytoplasmic one-carbon production and utilization ................................................... 19 
1.8 Removal of formate ........ .............. ...................................................................... .. ...... ................ 23 
1.9 Historical viewpoints of one-carbon metabolism ........................ .. ............... .......... ...... 24 
1.10 Biomedical aspects of formate ......................................................... ................................... 26 
1.11 Objectives ofresearch .............................. .......... ........................................ .. .. ......................... 26 
Chapter 2 - Methods .................................................................................... .............. ........ ............. ........ 29 
2.1 Chemicals ....................................................................................... .. .... ........................................... 30 
iv 
2.2 Animal care .................................................................................................................................... 30 
2.3 Preparation of diets ........................................................... .............. ........................................... 31 
2.4 Collection of urine ....................................................................................................................... 32 
2.5 Collection of blood ...................................................................................................................... 32 
2.6.1 Plasma formate concentration (formate dehydrogenase /diaphorase) .... .. 33 
2.6.2 Plasma formate concentration (GC-MS) .................................................................... 36 
2.6.3 13C-formate enrichment (GC-MS) ............................................................................... 37 
2.7 Formate concentration in urine (proton NMR) .............................................................. 38 
2.8 Measurement of urinary creatinine .................................................................................... 39 
2.9 Catalase activity ........................................................................................................................... 39 
2.10 Homocysteine in plasma by HPLC ..................................................................................... 40 
2.11 Statistics ...................................................................................................................................... .. 40 
Chapter Three- Optimization of a coupled assay with formate dehydrogenase and 
diaphorase for determining plasma formate concentrations ................................ .............. 41 
3.1 Experimental Approaches ................................................................................... .................... 42 
3.2 Results ........................................................................... .. ................................................................. 43 
3.3 Analysis .............................. .............................................................................................................. 47 
Chapter Four- In vivo kinetics; rates of endogenous formate production in control 
and folate-deficient rats ........................................................................................................................ 48 
4.1 Introduction ................................................................................................................................... 49 
4.2 Stable Isotopic Tracers .............................................................................................................. 49 
4.3 Procedure ......................................................................................................... .... ........................... 50 
4.4 Results ............................ ..................................................................... .......... ................................... 54 
4.5 Analysis ............................................................................................................................................ 61 
Chapter Five- Supplementation studies with dietary 1C precursors of the formate 
pool ................................................................................................................................................................ 64 
5.1 One-carbon precursor supplementation I ........................................................................ 65 
5.1.1 Introduction ....................... .................................................................................................... 65 
5.1.2 Results ......................................................................................... ............................................. 69 
5.2 Establishing another model for folate-deficiency in the rat. .................................... 75 
5.2.1 Selecting a diet ...................................................................................................................... 75 
v 
5.2.2 Establishing an experimental timescale .................................................................... 81 
5.3 One-carbon precursor supplementation II ...................................................................... 87 
5.3.1 Objectives ................................................................................................................................ 87 
5.3.2 Results ...................................................................................................................................... 92 
5.4 Comparison of 1C Precursor Supplementation Studies .. ........................................... 99 
5.5 Analysis ................................................................................................... ...................................... 103 
Chapter Six- General Conclusions and Future Work ........................................................... 105 
6.1 General Conclusions and Future Work ................... ........................................................ 106 
Bibliography ................................................................ .......... ........................ ...................... .................... 109 
Appendices ............................... ........................ ... ........................................................................... ......... 114 
vi 
List of Tables 
1.1 Oxidation states, and corresponding structures, of common 
folate-bound one-carbon groups and the associated free molecules .. .............................. 3 
4.1. Initial weights and specific growth rates (over final four days of 
experiment) of rats fed folate-deficient or folate-replete Dyets Inc. 
amino acid-defined diet (#517777 and #517802 respectively) ...................................... 52 
4.2. TTR (13C-formate to 12C-formate), plasma formate concentration 
and rate of endogenous formate production (per 100 g rat body weight) 
compared between folate-replete and folate-deficient rats having 
undergone a constant infusion of sodium 13C-formate (8.8 jlmol/hr) after 
attaining isotopic equilibrium .............................................................................................. 57 
4.3. Total1C potential from average daily consumption (23 g for a 200 g 
rat) of Dyets Inc. amino acid-defined diet.. .................. ....................................................... 59 
4.4. Estimation of quantity of known individual formate precursors that 
are required for net protein synthesis .... .. .. .......... .............. .... ................ .. .......................... 62 
5.1. Initial weights and specific growth rates (for final four days) of rats 
fed control versions of the folate-replete and folate-deficient Dyets Inc. 
L-amina acid-defined diet (#517802 and #517777 respectively) ................................... 66 
5.2. Initial weights for rats fed either the folate-replete or folate-deficient 
form of a commercially produced amino acid-defined diet (Dyets Inc.), or 
on an AIN-93G-based diet ........ ...... ...... ...... .......................................................................... 76 
5.3. Organization of 18 day one-carbon precursor supplementation 
study using AIN-93G-based diet (carried out using two cohorts of 
animals) ...... ................................................................................... ......................................... 88 
5.4. Initial weights and specific growth rates (over last four days of the 
experiments) of rats fed unsupplemented versions of the folate-deficient 
and folate-replete AIN 93G-based diet.. ............................................................................... 90 
vii 
List of Figures 
1.1. A simplified representation of the flow of one-carbon groups 
within a hepatic cell ............................................................................................................ 4 
1.2. The structures of folic acid (above) and naturally occurring 
tetrahydrofolate (below), in the mono-glutamate form ........ ............ ...................... .. ..... 6 
1.3. Serine hydroxymethyltransferase, using serine and THF as 
substrates, produces a bound one-carbon in the form of 5,10-
methylene THF as well as glycine ..................................................................................... 9 
1.4. Methionine metabolism in the context of one-carbon metabolism, 
consisting of the transmethylation cycle (SAM/SAH) and the. 
remethylation cycle (regenerating methionine from homocysteine) ......................... 12 
1.5. Histidine catabolism yields a one-carbon group by the conversion 
of N-formiminoglutamate (FIGLU) and THF to glutamate and 
5-formimino THF, catalyzed by glutamate formiminotransferase ............................ .. . 14 
1.6. The sequence of enzymatically catalyzed reactions in the catabolic 
pathway for choline and subsequent metabolites .. .. ..................................................... 15 
1.7. Tryptophan catabolism in the cytoplasm yields free formate ............................... 17 
1.8. Dietary one-carbon precursor catabolism pathways contributing 
to the mitochondrial one-carbon pool ...... .................. .................................................... 20 
1.9. Dietary one-carbon precursor catabolism pathways contributing 
to the cytoplasmic one-carbon pool, and pathways requiring one-
carbon groups ... .................................... ........................................................................... 22 
2.1 The two step enzymatic reaction involved in the enzymatic 
formate assay ........ ............................................................ .................. ...... ....................... 34 
3.1. A comparison of a deproteinized plasma (with diaphorase, NAD+, 
and I NT) after addition of both standard formate dehydrogenase (FD H) 
preparation and a FDH preparation processed using a PD-10 desalting 
column ..... ... ............................... ..... ......... .. .......... ..... ..................................................... . 44 
viii 
3.2. A comparison of a set of aqueous formate standards measured by 
two dye-reduction systems .......................... ... ........................................ ... ...... ..................... 46 
4.1. Average weights of rats fed either the folate-replete (cat. #517802) or 
folate-deficient (cat. #517777) version ofofthe Dyets Inc. amino acid-defined 
diet for 15 days ................. .................................................................. ............................ .. ... ... 53 
4.2. Typical timecourse for plasma formate concentration and TTR over 
-2 hours for a folate-replete rat undergoing a constant infusion of sodium 
13C-formate (8.8 11moljhr) ..................................................................................................... SS 
4.3. Typical timecourse for plasma formate concentration and TTR over 
-2 hours for a folate-deficient rat undergoing a constant infusion of sodium 
13C-formate (8.8 11moljhr) ..................................................... .. ............ , ............................... 56 
4.4. Comparison of rates of endogenous formate production between 
animals fed either a folate-deficient (Dyets Inc. #517777) or folate-
replete (Dyets Inc. #517802) diet for 15 days, and given a constant 
infusion of sodium 13C-formate (8.8 11moljhr) ............................................................. ...... 58 
4.5. Actual endogenous formate production compared to ingestion of 
potential formate precursors. Animals were fed either a folate-deficient 
(Dyets Inc. #517777) or folate-replete (Dyets Inc. #517802) diet for 15 
days, then given a constant infusion of sodium 13C-formate (8.8 11moljhr) ... .. .......... 60 
4.6. Comparison of the relationship between plasma formate concentration 
and the hourly rate of formate production between healthy and folate-
deficient animals. Animals fed either a folate-deficient (square points, 
Dyets Inc. #517777) or folate-replete (triangles, Dyets Inc. #517802) 
diet for 15 days, and given a constant infusion of sodium 13C-formate 
(8.8 11moljhr) ......................................................................................................................... 63 
5.1. Average weights of rats fed either the folate-replete (cat. #517802) or 
folate-deficient (cat. #517777) version ofofthe Dyets Inc. L-amino acid-
defined diet over the course of 15 days ................................................ .. .................. .... ...... 67 
5.2. Plasma formate level for rats fed a folate-replete L-amino acid-
defined diet (Dyets Inc. #517802) for 15 days, supplemented with 
extra one-carbon precursors for the final 3 days .............................................. .................. 70 
ix 
5.3. Plasma formate level for rats fed a folate-deficient L-amina acid-
defined diet (Dyets Inc. #517777) for 15 days, supplemented with extra 
one-carbon precursors for the final 3 days .......................................................................... 71 
5.4. 24 hour formate excretion, normalized to creatinine excretion, in the 
urine of rats fed a folate-replete L-amina acid-defined diet (Dyets Inc. 
#517802) for 15 days, supplemented with extra one-carbon precursors 
for the final 3 days .................................................. ............... ....... .. .... .. ...... oo ........ oo ... oo .... oo .. oo72 
5.5. 24 hour formate excretion, normalized to creatinine excretion, in the 
urine of rats fed a folate-deficient L-amina acid-defined diet (Dyets 
Inc. #517777) for 15 days, supplemented with extra one-carbon 
precursors for the final 3 day ...... oo .......... oo .... oo .. oo .... oo .... oo .... oo .... oo ...... oooooooo ............ oo .......... oo73 
5.6. Catalase activity in the livers of rats fed either a folate-deficient 
Dyets (cat. #517777) or folate-replete Dyets(cat. #517802) L-amina 
acid-defined diet for 15 daysoo.ooooo oooooo ....................................................... oo ............... oo ...... oo74 
5.7. Average weights of rats fed either a folate-replete or folate-deficient 
version of either an AIN-93G-based diet or amino acid-defined diet produced 
by Dyets Inc. (cat. #517777- folate-deficient, Cat. #517802- folate-replete) 
for up to 18 days ......... .. ....... oo.ooooooooooo ............. oo ............. oo .... oo.oo· ..... ... .... oo.ooooooooooo oooooooooooooooo.78 
5.8. Plasma formate concentration (y-axes; uM) of rats fed either an 
AIN-93G-based or amino acid-defined Dyets Inc. (Cat. #517777, 
517802) diet for either 9 or 18 days (both normal and folate-deficient varieties 
of each were tested) 000 000 ... 00 0 ... 000 00 ... . 000 oo. 000 00.000 000 ... 000 000 000 00.000 .... 00.00 00 0 000 000 oo· 00 0 000 000 oooo· oo· 000 000 000 00 0 79 
5.9. Plasma homocysteine concentration (y-axes; uM) of rats fed either 
an AIN-93G-based or amino acid-defined Dyets Inc. (Cat. #517777, 
517802) diet for either 9 or 18 days (both normal and folate-deficient varieties 
of each were tested) 000 000 000.00 000 00.000 00 .000 000 000 000 000 ... 000 ....... 00 000 ........................... 000 000 ........... oo 000000.80 
5.10. Average weights of rats fed either the folate-replete or folate-deficient 
AIN-93G-based diet for up to 30 days .. .. ...... oo ........ .. .... .. ........ oo .......... oo ........................ oooooo.82 
5.11. Plasma formate levels in rats fed an AIN-93G-based diet with and without 
folic acid for up to 30 days (n=3) .............................. oo .... oo .. oooo .... oo ...... .... .. .. .......... oo .......... oo.83 
X 
5.12. Plasma homocysteine levels in rats fed an AIN-93G-based diet with and 
without folic acid for up to 30 days (n=3) ............................................................................ 85 
5.13. 24 hour formate excretion in urine, normalized to creatinine excretion, for 
rats fed an AIN 93G-based diet with and without folic acid for up to 30 days (n=3) ...... 86 
5.14. Average weights of rats fed either the folate-replete or folate-deficient 
version of an AIN-93G-based diet over the course of 18 days .................. .. ....................... 91 
5.15. Plasma formate concentration for rats fed a folate-replete AIN-93G-
based diet for 18 days, supplemented with an extra 46 mmoljkg diet of 
individual one- carbon precursors for the final 5 days .................................. .... .. .. ............ 93 
5.16. Plasma formate concentration for rats fed a folate-deficient AIN-
93G-based diet for 18 days, supplemented with an extra 46 mmoljkg. 
diet of individual one-carbon precursors for the final 5 days ........................................... 94 
5.17. 24 hour formate excretion, normalized to creatinine excretion, in the 
urine of rats fed a folate-replete AlN-93G-based diet for 18 days, 
supplemented with an extra 46 mmoljkg diet of individual one-carbon 
precursors for the final 5 days .................. .................................................... .. ..................... 95 
5.18. 24 hour formate excretion, normalized to creatinine excretion, in the 
urine of rats fed a folate-deficient AIN-93G-based diet for 18 days, 
supplemented with an extra 46 mmoljkg diet of individual one-carbon 
precursors for the final 5 days .... .. ........................................................ .............. .... ............. 96 
5.19. Plasma homocysteine concentration in rats fed a folate-replete 
AIN-93G-based diet for 18 days (supplemented with an extra 46 
mmoljkg diet of individual one-carbon precursors for the final 5 days) ...... .................. 97 
5.20. Plasma homocysteine concentration in rats fed a folate-deficient 
AIN-93G-based diet for 18 days (supplemented with an extra 46 
mmoljkg diet of individual one-carbon precursors for the final 5 days) ....................... 98 
5.21. The plasma formate concentration of rats fed either an AIN -93G-
based diet or a Dyets Inc diet (for 18 and 15 days respectively) .............. .. .......... ...... .. .. 100 
xi 
5.22 24 hour formate excretion, normalized to creatinine excretion, 
of rats fed either an AIN-93G-based diet or a Dyets Inc diet (for 18 
and 15 days respectively) ... ..... ............ ................... ............. .......... ...................... ... ... ... ...... 101 
5.23. The plasma formate concentrations of rats fed either an AIN-93G-
based diet or a Dyets Inc diet (for 18 and 15 days respectively) supplemented 
with extra histidine or serine .. .......... .... ............. ..... .. .................... ..... ...... .... ................... ......... 102 
xii 
lC 
AIN 
AMT 
amu 
BHMT 
DMG 
OTT 
FDH 
FIGLU 
GC-MS 
GCS 
GNMT 
HPLC 
INT 
List of Abbreviations 
One-carbon 
American Institute of Nutrition 
Aminomethyltransferase 
atomic mass unit 
Betaine:homocysteine methyltransferase 
Dimethylglycine 
Dithiothreitol 
Formate Dehydrogenase 
Formiminoglutamate 
gas chromatograph with mass spectrometer 
Glycine cleavage system 
Glycine-N-methyltrasnferase 
High Performance Liquid Chromatograph 
Iodonitrotetrazolium 
MTHFR 5,10-methylene tetrahydrofolate reductase 
NMR 
PFBBr 
PMS 
SAH 
SAM 
SGR 
SHMT 
Nuclear magnetic resonance 
Pentafluorobenzyl bromide 
Methoxy 5-methyl phenazinium methylsulfate 
S-adenosyl homocysteine 
S-adenosyl methionine 
Specific growth rate 
Serine-hydroxymethyltransferase 
xiii 
THF Tetrahydrofolate 
TTR Tracer: tracee ratio 
USP United States Pharmacopeia 
WST-1 Water soluble tetrazolium-1 salt 
xiv 
List of Appendices 
Appendix A- Plasma formate under a variety of physiological situations .... ... ....... 112 
Appendix B- Comparison of amino acid composition of diets ................ ............... 114 
Appendix C- Experimental diets (compositions, mineral mixes, 
and vitamin mixes) ........... .................. ... ................... ... ................. ...... ............... ......... . 115 
Appendix D- Dyets Inc. amino acid-defined diet (cat. #517777, 
#517802) 1C precursor supplementation trial diet modifications ........................ 120 
Appendix E- AIN-93G-based 1C precursor supplementation trial 
diet modifications .. ..................... ............ ..................... ............. ..... ...................... .. ...... 121 
XV 
Chapter One- Introduction 
1 
1.1 One-carbon metabolism 
One-carbon metabolism refers to the set of reactions which procure single 
carbon units, primarily from dietary sources, for the production of DNA bases 
(purines and thymidylate) as well as providing methyl units for S-adenosyl 
methionine (SAM, the universal methyl donor)(l). This pool of one-carbon units is 
created and replenished by the catabolism of a variety of precursors (primarily 
amino acids and choline) found in the diet (2). Some of these reactions provide a 
single one-carbon unit, while others are capable of donating several one-carbon 
units through consecutive catabolic reactions. Many of these reactions require a 
folate co-substrate for the reaction to proceed, whereas others proceed 
independently. In the case of those pathways requiring folate as a co-substrate, the 
resultant one-carbon unit will be integrated into a folate structure. In the absence of 
a folate, the one-carbon group produced will be formate, the simplest carboxylic 
acid. 
Prior to utilization, one-carbon groups must be integrated into the folate 
pool. They can then be shuttled to their respective usages. In this manner, a cell's 
complete one-carbon pool exists as both free formate as well as one-carbon groups, 
in a variety of oxidation states, associated with tetrahydrofolate (THF) (see Table 
1.1). The body has several ways of eliminating excess one-carbon groups, including 
oxidation to carbon dioxide or through the excretion of formate in the urine. Figure 
1.1 provides a simplified schema for one-carbon metabolism in the context of a 
hepatic cell. 
2 
Table 1.1 Oxidation states, and corresponding structures, of common folate-bound 
one-carbon groups and the associated free molecules below. 
Folate-bound one-carbon Structure Equivalent Free Molecule 
CH 3 H N ·---·-·-· Methanol 
5-methyl THF I I CH30H 
____ -N'--/ 
' ' 
' 
' 
' 
' 
H C N ·--·-- ... Formaldehyde _)~ 5,10-methylene THF HCHO 
-
' 
' 
' 
' 
0 
HAN ----- Formic Acid 
10-formyl THF / ~  HCOOH 
' 
' 
' 
' 
Note: This table is an abridged version of a similar table found on page 114 of the 
above citation (2). This is included due to the importance of these structures to the 
work contained in this thesis. 
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Choline 
Serine 
Glycine 
THF : 
~ 
. 
. 
. 
. 
' ' 
' 
Mitochondria 
C02 ~Formate 
Formyl THF 
' 
~ 
' 
' , 
..... , ..... 
---
Bloodstream 
Cell 
\Tryptophan\ 
1 
Formate 
Cytosol 
' 
' 
.... 
\ Methionine\ 
J. 
Formate 
C§V 
Figure 1.1. A simplified representation of the flow of one-carbon groups within a 
hepatic cell. One-carbon precursors are surrounded by a box. Reactions/processes 
consuming or removing one-carbon units from the cellular pool are highlighted with 
an oval. Bound one-carbon groups (indicated with a THF) are restricted to either 
the cytoplasm or mitochondria, whereas free formate can be transported across the 
mitochondrial membrane. 
4 
1.2 Folate 
Folate, in the broadest definition, can be considered as a water-soluble B-
vitamin (B9), derived either naturally from the diet (primarily dark green leafy 
vegetables such as spinach) or synthetically as a more oxidized product, folic acid 
(3). Despite some structural differences between these two sources, the backbone of 
both forms of this vitamin is identical (see Figure 1.2). The one-carbon binding 
domain is located on a pteridine structure, with one-carbon groups binding to one or 
both of the NS or NlO atoms(4). The pteridine structure is bound to a p-
aminobenzoic acid derivative, which in turn connects to a glutamate tail of between 
one and eight residues connected by isopeptide bonds. 
A major difference between natural folate and synthetic folic acid lies in the 
poly-glutamate tail found in the naturally occurring variants of folate(5) . Natural 
folate will bear a polyglutamate tail of between four and seven glutamate residues 
( 4). Bioavailability is defined as the proportion of an ingested compound that is 
actually absorbed from the diet (and used by the body) to the total dietary 
availability ( 6). In the case of folate, bioavailability depends on the length of the 
glutamate tail. The human genome codes for a protein in the intestinal lining called 
glutamate carboxypeptidase II (GCPII) which cleaves polyglutamate residues, 
reducing the folate to a monoglutamate form. After ingestion, all residues in excess 
of a single glutamate must be cleaved enzymatically prior to absorption in the gut, a 
step which can prove rate-limiting (7). Accordingly, the absence of an extended 
glutamate tail on synthetically-derived folic acid can increase vitamin absorption in 
5 
0 
~ I I 
0 H ~I~ ~H 
II N J,~ /: 0 N~ 'Y"'N / 
H N)lN_)lN) H 0"' OH 
2 
H H OH 
Figure 1.2. The structures of folic acid (above) and naturally occurring 
tetrahydrofolate (below), in the mono-glutamate form. Note the reduced double 
bonds on the pteridine subunit on the tetrahydrofolate structure. Arrows indicate 
the NS (left) and N10 (right) positions, to which one-carbons units can be bound. 
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an organism. Consequently, the bioavailability of a polyglutamated folate is less than 
that of the monoglutamated form by 20-40%; therefore synthetic folic acid is more 
bioavailable than natural folate. The location and existence of this peptidase 
suggests a preference for absorption of monoglutamated folate. 
Due to the enzymatic hydrolysis of these glutamates, all natural folates 
entering the cell will bear mono-glutamate tails. The final step prior to integration 
into one of the cellular folate pools is the introduction of a poly-glutamate tail(B). 
Although monoglutamate folates can be transported throughout the body, the action 
of folyl-polyglutamate synthetase is required to retain folates within their cellular 
pools. After the addition of extra glutamate residues, a folate will be able to 
participate in the one-carbon reactions relevant to its pool. Although one-carbon 
precursors and formate may travel between compartments, activated folates remain 
segregated. The majority of folates will be localized to either the cytoplasm or 
mitochondria with a smaller portion in the nucleus ( 4). 
The second difference between the dietary sources of folate is the oxidative 
state at which the molecule enters the body. Whereas natural folate can be 
integrated directly into the cellular folate pools, synthetic folic acid is produced in a 
more oxidized form, and must first undergo an intracellular two-step enzymatic 
reduction catalyzed by dihydrofolate reductase(9). This cytoplasmic reaction 
reduces two carbon-nitrogen double bonds located on the pteridine sub-structure to 
single bonds, and is necessary before synthetic folic acid can be integrated into one-
carbon metabolism. 
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1.3 Formate increases during folate deficiency 
Formic acid is the simplest carboxylic acid. Tissues responsible for formate 
production have not been definitively identified. It is possible some format is 
produced by gut microorganisms. With a pKa of -3.7, most formic acid occurs in the 
body as formate (the un-protonated form) (10). Since incorporation of formate into 
the folate pool occurs in the cytoplasm and much, if not most, formate production 
occurs in mitochondria, a means of transporting formate from mitochondria to 
cytoplasm is required (2). Recent work from our lab has demonstrated that in 
addition to the elevated excretion of formate in urine during folate deficiency (11), 
the plasma formate concentration also increases up to seven-fold (12), compared to 
that in healthy folate-replete rats. Plasma formate levels under various 
physiological conditions are provided in Appendix A. Renal handling of formate has 
not been studied in detail. 
In humans (but not in rats), formate is the first product in the methanol 
catabolism pathway. Both ocular damagae and acidosis can be attributed to the 
accumulation of formic acid due to methanol overdose(12). 
1.4 Folate-mediated one-carbon production 
1.4.1 Serine 
The catabolism of dietary serine has the potential to yield two one-carbon 
groups. Serine and THF can be converted, via serine hydroxymethyltransferase 
(SHMT), to 5,10-methylene THF and glycine (Figure 1.3). Two separate isoforms of 
this enzyme are coded for in the nuclear DNA, one of which is expressed in the 
cytoplasm (SHMTl) and one of which is expressed in the mitochondria (SHMT2) 
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Serine 
THF 
5,1 O-m ethylene THF 
Serine hydroxymethyltransferase 
H2N-CH2-COOH 
Glycine 
Figure 1.3. Serine hydroxymethyltransferase, using serine and THF as substrates, 
produces a bound one-carbon in the form of 5,10-methylene THF as well as glycine. 
The resultant glycine can either be catabolized to produce another one-carbon, or 
can be used by the body for protein synthesis or other purposes. 
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(13, 14). Gregory eta!. (15) recently employed tracer methodology to suggest that 
serine catabolism is responsible for the majority of one-carbon units provided for 
the cytoplasmic transmethylation cycle. 
Stover eta!. (16) recently used a mouse knockout model of cytoplasmic SHMT 
to investigate the extent of this enzyme's role in thymidylate synthesis. They found 
knocking out SHMTl resulted in diminished thymidylate production along with the 
onset of neural tube defects in developing mouse embryos. This demonstrated the 
importance of serine-derived one-carbon groups in thymidylate biosynthesis. 
Further work by Anderson and Stover ( 17) demonstrated that the mitochondrial 
SHMT2 gene has an alternate splice variant that allows for localization, in lesser 
quantities, to the cytoplasm and nucleus. Survival of mice with a homozygous 
SHMTl knockout is attributed to the small activity provided by the cytoplasmic and 
nuclear variants of this alternate SHMT2 expression. 
1.4.2 Glycine 
Unlike SHMT, which is active in both the cytoplasm and mitochondria, the 
multi-enzyme complex responsible for the catabolism of glycine is only expressed in 
the mitochondria(18). The Glycine Cleavage System (GCS) is made up of four 
components acting in concert; glycine dehydrogenase, aminomethyltransferase 
(AMT), GCS protein Hand dihydrolipoamide dehydrogenase. The GCS is also 
involved in the last of several sequential mitochondrial catabolic reactions that 
remove and activate one-carbon groups for choline (see final reaction of choline 
catabolic pathway, Figure 1.6). 
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Narisawa et al. (18) used a knockout mouse model in which AMT was 
eliminated, resulting in neural tube defects in developing mouse embryos. This 
highlights the importance of glycine-derived one-carbon groups produced in the 
mitochondria to the one-carbon pool. 
1.4.3 Methionine 
Methionine contributes to the cytoplasmic one-carbon pool indirectly through its 
incorporation into S-adenosyl methionine (SAM), which is the key substrate for the 
process of transmethylation (19) (Figure 1.4). Methyltransferases act on nucleophilic 
substrates, to produce methylated products and SAH (S-adenosyl-L-homocysteine). 
Glycine-N-methyltransferase (GNMT) serves in an overflow mechanism such that if the 
cell generates more SAM than it requires for methylation and other reactions, the 
methyl group may be transferred to glycine, creating sarcosine (20). Sarcosine is 
subsequently catabolized through the choline degradation pathway, thereby 
contributing directly to the mitochondrial 5,10-methylene THF pool. The SAH 
produced by methyltransferase reactions is hydrolyzed to adenosine and homocysteine. 
Re-methylation of homocysteine regenerates methionine with methyl groups provided 
by betaine (catalyzed by betaine:homocysteine methyltransferase) or 5-methyl THF 
(catalyzed by methionine synthase). This regeneration process requires a one-carbon 
unit, ultimately contributed by choline via betaine (BHMT) (15), serine (via cytoplasmic 
SHMT) (21), or formate. 
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Figure 1.4. The methionine cycle in the context of one-carbon metabolism, 
consisting of transmethylation (SAM/SAH) and remethylation reactions 
(regenerating methionine from homocysteine) . (BHMT: Betaine:homocysteine 
methyl transferase) 
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1.4.4 Histidine 
Histidine is metabolized by a series of cytoplasmic enzymatic reactions 
ultimately yielding formiminoglutamate (FIGLU), as shown in Figure 1.5 (22). The 
formimino component of FIGLU is transferred to a THF co-substrate by glutamate 
formiminotransferase yielding 5-formimino THF. This is subsequently converted to 5,10-
methenyl THF by 5-formimino THF cyclodeaminase. The resultant one-carbon group 
can then be shuttled to pathways requiring one-carbon units. 
1.4.5 Choline 
Choline is unique among the one-carbon precursors in that it has the ability 
to donate up to four of its constituent carbons to the one-carbon pool (see Figure 
1.6). Choline is initially catabolized to betaine aldehyde and subsequently to betaine 
by choline dehydrogenase and betaine aldehyde dehydrogenase respectively (23). 
Both of these reactions occur in the mitochondria. 
Betaine must be exported to the cytoplasm where betaine:homocysteine 
methyltranferase (BHMT) uses one of its methyl groups to regenerate methionine, 
forming dimethylglycine (DMG). This methionine can, of course, be employed for 
SAM production, as well as other metabolic fates (such as protein synthesis). DMG 
can be transported into the mitochondria, where three sequential enzymatic 
reactions remove its three carbons sequentially. Specifically, DMG dehydrogenase 
converts DMG to sarcosine, followed by sarcosine dehydrogenase which converts 
sarcosine to glycine(24). 
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Figure 1.5. Histidine catabolism yields a one-carbon group by the conversion of N-
formiminoglutamate (FIGLU) and THF to glutamate and 5-formimino THF, catalyzed 
by glutamate formiminotransferase. 
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Figure 1.6. The sequence of enzymatically catalyzed reactions in the catabolic 
pathway for choline and subsequent metabolites (18, 27). 
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Finally glycine is catabolized to ammonia and carbon dioxide by the glycine cleavage 
system (described in detail in Section 1.4.2)(18). Each of these reactions requires 
THF as a co-substrate and produces a mitochondrial molecule of 5,10-methylene 
THF. 
1.5 Folate-independent one-carbon production 
A number of metabolic processes can yield free formate independent of THF. 
These include the catabolism of tryptophan, the a-oxidation of branched chain fatty 
acids, cholesterol biosynthesis, and the metabolic removal of methanol. This formate 
can then be incorporated into the folate-bound one-carbon pool by 10-formyl THF 
synthetase (located in both mitochondria and cytoplasm), and can be shuttled on to 
various fates(25) . 
1.5.1 Tryptophan 
Tryptophan catabolism involves a step where a formyl group is cleaved in a 
folate-independent manner to produce formate (see Figure 1.7). Tryptophan is 
oxidized by tryptophan dioxygenase to N-formylkynurenine, which is subsequently 
converted to kynurenine and formate by kynurenine formamidase (26). 
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Figure 1. 7. Tryptophan catabolism in the cytoplasm yields free formate. 
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1.5.2 Other sources of folate-independent formate 
There are a number of other reactions that can produce one-carbon groups that 
do not feature the catabolism of precursors such as amino acids and choline. This 
includes the production of cholesterol (27 carbons) from its precursor lanosterol (30 
carbons), during which one of the supernumerary carbons is released as formate (28). 
Another pathway that is responsible for formate production is the metabolism of 
branched chain fatty acids through a-oxidation(29); this occurs in peroxisomes. Any 
organism consumes vegetable matter ingests phytanic acid, the branched chain fatty 
acid responsible for anchoring chlorophyll in chloroplast membranes. Lastly, methanol 
will be metabolized to formaldehyde and subsequently to formate by alcohol 
dehydrogenase and formaldehyde dehydrogenase respectively (30). 
1.6 Mitochondrial one-carbon production and utilization 
As previously discussed, the mitochondrial one-carbon pool is provided by the 
catabolism of choline, serine, methionine and glycine. Each of these produces one or 
more 5,10-methylene THF units. Since one-carbon units are utilized in the cytoplasm, 
the mitochondrial 5,10-methylene group on THF must first be converted to free formate 
for export across the inner mitochondrial membrane. The release of free formate is 
facilitated by C1- THF synthase, a trifunctional enzyme which is responsible for the two-
step process which results in the production of 10-formyl THF (25). Initially, 5,10-
methylene THF dehydrogenase oxidizes 5,10-methylene THF to 5,10-methenyl THF 
(accompanied by the reduction of NADP+ to NADPH). This is followed by the conversion 
of 5,10-methenyl THF to 10-formyl THF by the action of 5,10-methenyl THF 
cyclohydrolase. 
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The release of formate from 10-formyl THF is catalyzed by 10-formy/ THF 
synthase, a third component of the trifunctional C1-THF synthase(31). This 
produces one ATP in the process. Alternatively, in the presence of NADP+, 10-formyl 
THF dehydrogenase can release the carbon as carbon dioxide, in a reaction that may 
serve to remove excess one-carbon potential. Once produced, formate can be 
transported out of the mitochondria, while the THF will be reused as a co-substrate 
in another mitochondrial one-carbon producing reaction. Figure 1.8 provides an 
illustration of the important reactions described above. 
1.7 Cytoplasmic one-carbon production and utilization 
The cytoplasmic one-carbon pool is more complex than the mitochondrial 
pool because it entails both the production and utilization of one-carbon groups, the 
import and export of one-carbons, as well as the inter-conversion of a number of 
different forms ofTHF-bound, one-carbon units. Figure 1.9 provides an overview of 
some of these processes. 
Free formate, produced in mitochondria from the catabolism of serine, 
glycine, methionine and choline can be imported into the cytoplasm( 4). This 
formate can also be supplemented by a number of folate-independent, one-carbon 
producing reactions that yield formate (as previously discussed) such as tryptophan 
catabolism, methanol metabolism, a -oxidation of branched chain fatty acids. 
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Figure 1.8. Catabolic pathways for dietary one-carbon precursors that contribute to 
to the mitochondrial one-carbon pool. The mitochondrion is shaded a light gray and 
dietary one-carbon precursors are surrounded by a rectangle. A box surrounds the 
three enzymatic activites making up the trifunctional C1-THF synthase. 
Enzyme Abbreviations: BHMT- Betaine:homocysteine methyl transferase, CDH-
Choline dehydrogenase, DOH- Dimethylglycine dehydrogenase, GCS- Glycine 
cleavage system, GNMT- Glycine-N-methyltransferase, SOH- Sarcosine 
dehydrogenase, SHMTM- Serine hydroxymethyltransferase mitochonctriai, THFCH-
5,10-methenylTHF cyclohydrolase, mTHFDH- 5,10-methyleneTHF dehydrogenase, 
ITHFDH- 10-formyl THF dehydrogenase, THFS- 10-formyl THF synthase 
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Figure 1.9. Dietary one-carbon precursor catabolism pathways contributing to the 
cytoplasmic one-carbon pool, and pathways requiring one-carbon groups. A box 
surrounds the three enzymatic activities making up the trifunctional C1-THF 
synthase. 
Enzyme Abbreviations: MTHFR- 5,10-methylene THF reductase, SHMTc - Serine 
Hydroxymethyltransferase cytoplasmic, THFCH- 5,10-methenylTHF cyclohydrolase, 
THFDH- 5,10-methyleneTHF dehydrogenase, THFS -10-formyl THF synthase 
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Some of the formate will be used by the organism for constructive purposes 
following integration into the folate-bound cytoplasmic one-carbon pool. 10-formyl 
THF synthetase converts formate and THF to 10-formyl THF. This action is one of 
three functional domains of the C1-THF Synthase enzyme, which also contains 5,10 
methylene THF cyclohydrolase and 5,10-methenyl dehydrogenase. These functional 
domains allow for the interconversion of 10-formyl THF to 5,10-methenyl THF, and 
5-10 methenyl THF to 5,10-methylene THF respectively. 5,10-methylene THF can 
be reduced one step further to 5-methyl-THF by NADPH, a reaction catalyzed by 
5,10-methylene THF reductase. Pathways requiring one-carbon groups will use one 
of the four THF structures mentioned. One-carbons fated for methyltransferases will 
be fed into the transmethylation cycle via 5-methyl THF's remethylation of 
homocysteine to methionine (21). Purine synthesis requires two formyl groups 
from 10-formyl THF to provide C2 and C6 of the purine molecule (32). Thymidylate 
(dTMP) is created from dUMP by the action ofthymidylate synthase, a reaction 
requiring 5,10-methylene THF as the substrate (33) . 
1.8 Removal of formate 
Metabolic activity is linked to the production of reactive oxygen species such 
as hydrogen peroxide. (34) Among an organism's general defenses against oxidative 
damage is the enzyme catalase. Catalase is among the most active and ubiquitous 
enzymes in the biosphere, responsible for the removal of hydrogen peroxide via a 
dismutative mechanism. A secondary function of catalase is the peroxidizing 
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decomposition of various hydrogen donors (such as formic acid), which occurs in 
the presence of a corresponding quantity of peroxide (see equation 1). 
H202 + COOH2 -7 ZH20 + C02 (1) 
This secondary activity of catalase provides another mechanism for the removal of 
excess one-carbon units from the cell. 
In addition to catalase, a number of other significant mechanism exist which 
clear formate. Formate may be oxidized to carbon dioxide, which may be then 
removed from the body by gas exchange in the lungs. This occurs both in the 
mitochondria as well as in the cytoplasm. Mitochondrial-derived formate can also 
be exported to the cell where it may be incorporated into the cytoplasmic 1C 
pool(12). 
1.9 Historical viewpoints of one-carbon metabolism 
Literature concerning the relationship between folic acid and formate begins 
to appear in the late 1940s to early 1950s, mainly describing studies making use of 
radiolabelled molecules (tracers). Radioactive dietary formate precursors and 
radioactive formate were used to measure the relative contributions to the formate 
pool and the fates of formate respectively(35, 36). Several points stand out as to the 
difference between these historical interpretations and our contemporary 
understanding of one-carbon metabolism. Although there was discussion of the 
relationship between formate and folate, there is no clear indication in the early 
work that folate is directly involved as a substrate and carrier in one-carbon 
producing reactions (11, 37), nor was there a clear understanding of the relevant 
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enzymes as we now know them. On a similar note, while we now understand that 
both folate-bound and free variants are at play in the supply and utilization of one-
carbon units, the early literature refers to this pool exclusively as "formate", and we 
find that there is no discussion of the folate being used as a carrier of one-carbon 
units. 
Tangential work in the field of microbiology determined that inhibiting the 
production of p-amino benzoate (PABA, a precursor and structural constituent of 
folate) in Escherichia coli would reduce the production of purines(38). Plaut et al. 
(37) recognized the relationship between PABA and folate and drew the correct 
conclusion that folic acid was somehow involved in the production of purines. 
Further work determined that folate-mediated, one-carbon metabolism was 
responsible for incorporating the carbons at positions 2 and 8 of the purine rings 
(35). They took this a step further and noted that in those animals deficient in folate, 
less radioactive formate was incorporated into liver purines than those animals 
supplemented with folate(35). This work provided a link between formate 
metabolism and purine production without offering a specific mechanism. The 
authors note that folate "controls the incorporation of formate" into the purines 
without explicitly understanding that folate acts as the carrier of the one-carbon 
group. 
Modern reviews of the relevant literature identify the provisioning of one-
carbon units towards purinejthymidylate production and methyltransferases as the 
'raison d'etre' for folate-mediated one-carbon metabolism(l). By contrast, some 
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early papers were concerned with the contributions of formate towards the 
interconversion and production of amino acids. Early work from Plaut's laboratory 
centered on the incorporation of free formate into amino acids in folate-replete and 
folate-deficient animals (37). Although it is recognized that serine can be produced 
from glycine due to the bi-directional nature of SHMT, this no longer seems to be 
emphasized as a key factor in maintaining serine levels. In fact, modern work has 
tended towards the opposite, suggesting that serine catabolism (producing glycine) 
is the principal source of one-carbon units used to re-methylate homocysteine to 
provide methionine for use in the transmethylation cyc!e(15). 
1.10 Biomedical aspects of formate 
Formate plays an important clinical role in the identification and 
management of chronic alcohol abuse. Kapur eta!. showed that the mean plasma 
formate levels were significantly higher in alcoholics as compared to control 
patients. A supplementation ofTHF was able to lower the plasma formate 
concentration and mitigate the neurotoxicity observed in control chronic alcoholics 
(56). 
1.11 Objectives of research 
The experimental work contained within this thesis contributed towards four 
broad aims. 
1. Optimization of a coupled assay with formate dehydrogenase and 
diaphorase to determine plasma formate concentrations in an accurate and efficient 
manner. The ability to reliably assay the formate concentration of plasma was 
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absolutely essential for most of our work, necessitating a method that was both 
efficient and high-throughput. We set to work optimizing an enzyme-based 
spectrophotometric assay and adapting it to a microplate reader. Initial tests 
revealed that even after the assay came to completion, the apparent absorbance 
would continue to increase (non-specifically) in a linear fashion. This "creep" was 
eliminated following systematic testing of different tetrazolium dyes and oxidation-
reduction couplers, along with the use of a miniature desalting column to remove 
impurities from the commercial enzyme preparations. As a result, we were able to 
increase the utility of the assay at minimal cost and with no increase in time. 
2. Establishment of a robust model of folate deficiency in the rat. Initial work 
on folate-deficiency was carried out using a standard, commercial folate-deficient 
diet in which free amino acids replaced protein. It was observed that even on a 
relatively short timescale (15 days), there were apparent differences in the weight 
gain between folate-replete and folate-deficient animals. In order to carry out our 
final two objectives, we experimented with changing the diet and/or experimental 
timescale such that our animals were as healthy as possible while maintaining 
symptoms of folate-deficiency (elevated plasma formate and homocysteine). This 
work comprised two studies. Initially we compared plasma formate, and plasma 
homocysteine concentrations between the commercially-sourced amino acid-
defined diet and a folate-deficient casein-based AIN-93G diet, produced in-house. 
After switching to the AIN-93G diet, we ran a second experiment to determine the 
optimal length of feeding. 
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3. Determination of in vivo kinetics/endogenous formate production in 
control and folate-deficient rats. Although early work demonstrated a difference in 
the "static" concentrations of plasma and urinary formate between folate-replete 
and folate-deficient rats, limited work has been conducted concerning the rates of 
production. Using a constant infusion of sodium 13C-formate, we found a significant 
difference in rates of free formate production between healthy and folate-deficient 
animals. Knowing the quantities of food ingested, and the content of potential one-
carbon groups in the food, we compared the relationship between ingested potential 
formate precursors and the rate of endogenous formate production between folate-
replete and folate-deficient animals. 
4. Determination of the importance of particular dietary one-carbon 
precursors. After determining the proper diet and timescale, we ran a series of 
experiments in which we increased, one at a time, the dietary concentration of a 
variety of known or suspected one-carbon precursors. These experiments were 
conducted in both healthy and folate-deficient animals. We compared the mean 
plasma formate and urine formate concentration in each precursor-supplementation 
group against their respective healthy or folate-deficient control. In those cases 
where there was a significant increase in plasma or urine formate excretion above 
the control group, we concluded that the increased formate precursor supply was 
responsible and that the precursor in question might therefore be an important 
donor to the free one-carbon pool. 
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Chapter 2 - Methods 
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2.1 Chemicals 
Formate dehydrogenase (isolated from Candida Boidinii, Cat. # F8649) and 
pentafluorobenzyl bromide (PFBBr) were obtained from Sigma Aldrich (U.S.A), 
Diaphorase (isolated from Clostridium kluyveri) was obtained from Worthington 
Biochemical (U.S.A.). Sodium 13C-acetate and sodium BC-formate were obtained 
from Cambridge Isotopes (U.S.A.). Sodium pentobarbital was obtained from Ceva 
Sante Animale (France). Acetonitrile (HPLC grade) was obtained from Fisher 
Scientific (U.S.A). Isoflurane was obtained from Abbott Animal Health (U.S.A.). Gas 
cylinders were procured from Air Liquide Canada, at the quality appropriate for 
biological use (U.S.P. grade). Unless otherwise noted, all other chemicals were 
procured from Sigma-Aldrich, and all solvents from Fischer Scientific. 
2.2 Animal care 
All studies were conducted with male Sprague-Dawley rats sourced from the 
Vivarium, operated by Memorial University's Animal Care Services Department. 
These were delivered to us shortly following weaning ( 4 weeks of age), were 
weighed and were housed individually in clear cages in a temperature and humidity 
controlled facility. Lighting was controlled by computer and followed a twelve 
hours on, twelve hours off routine (7 AM lights on, 7PM lights off). Animals were fed 
one of two purified experimental diets, depending on the particular experiment 
(these are described subsequently). Blood and tissue samples were taken from 
anesthetised rats (sodium pentobarbital i.p., 5.5 mg/100g body weight). For the 
constant infusion experiments, rats were anesthetised with isoflurane in oxygen 
(induced at 4%, maintained at 2%) using U.S.P. grade oxygen as the carrier gas. All 
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animal protocols were approved by the Institutional Animal Care Committee of 
Memorial University of Newfoundland and were in accordance with the Guidelines 
of the Canadian Council on Animal Care. 
2.3 Preparation of diets 
Two diets were employed in this work, both of which were used to induce 
moderate folate-deficiency in our experimental animals. The first is an amino acid-
defined diet produced commercially by Dyets Inc (Bethlehem, PA), (folate deficient-
#517777, folate-replete- #517802). It was a modified (39) version ofClifford-
Koury's original folate-deficient diet ( 40). The second diet was a growth-enabling 
form of the rodent casein-based diet endorsed by the American Institute of 
Nutrition, known as AIN-93G ( 41). The amino acid profiles of these diets were 
compared in Appendix B. The compositions of both diets were included in Appendix 
C. These diets were modified to allow both folate-replete and folate-deficient forms 
of the respective diets. 
With the exception of amino acids and the following specific components, all 
dietary ingredients were sourced from MP Biomedical (formerly ICN), a corporation 
which markets chemicals specifically for use in research diets. Mineral mixes and 
vitamin mixes were obtained from Dyets Inc. Tert-butylhydroquinone was obtained 
from Sigma-Aldrich. 
In the course of conducting precursor supplementation studies, we increased 
particular known and suspected one-carbon precursors at the expense of other 
ingredients. These additions accounted for, at most, around one percent of the total 
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diet. The commercial amino acid-defined diet (Dyets) came premixed, so all other 
ingredients were scaled back according to how much precursor we wished to 
supplement. When we switched to the AIN-93G diet, which we prepared in-house 
from separately sourced ingredients, we were able to offset precursor addition 
through the reduction of specific ingredients. Since corn starch was present in the 
greatest quantity, it was scaled back according to the mass of the 1C precursor 
supplemented in a particular diet. These modifications are discussed as they arise. 
Our Dyets Inc. diets were analyzed in the lab of Dr. MacFarlane (Ottawa) of 
Health Canada to determine their folate content. This analysis employed a 
microbiological assay using Lactobacillus Casei grown in a medium lacking folic 
acid( 42). The general principle was that the turbidity of the final culture would be 
proportional to the extent of L.Casei proliferation, which would depend directly on 
the quantity of folate present in the diet sample. 
2.4 Collection of urine 
Urine collection always took place on the penultimate day of a study, or one 
day prior to blood and tissue sampling. Animals were placed in metabolic cages in 
the morning, and the urine collection tube was spiked with 25 IlL of 80 mM sodium 
azide to act as a preservative ( 43). Collection ran for 24 hours. 
2.5 Collection of blood 
Following induction of anesthesia, rats were dissected so as to expose the 
peritoneal cavity (from below the intestines to just below the diaphragm). At all 
times, great care was taken not to puncture or disturb the chest cavity. Saline-
soaked gauze was used to expose the abdominal aorta. Approximately 3mL of blood 
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were taken into a heparinized syringe. This blood was stored in glass tubes on ice, then 
centrifuged at 1800 RPM (550g) for 10 minutes to separate the plasma which was 
subsequently stored in 1.5 mL aliquots at -80° C. 
2.6.1 Plasma formate concentration (formate dehydrogenase /diaphorase) 
The enzymatic formate assay is based on a coupled enzymatic reaction involving 
formate dehydrogenase (FDH) and diaphorase (see Figure 2.1). It was designed as a 
traditional spectrophotometric assay ( 44), but we optimized it for microplates. The 
basic reagents were unchanged, but their concentrations varied and total assay volume 
was less. FDH oxidized formate to COz while simultaneously reducing NAD+ to NADH. 
Diaphorase then recycled NADH back to NAD+ while simultaneously reducing 
iodonitrotetrazolium chloride (!NT) to its formazan dye which had a peak absorbance 
at 500 nm. Thus, the change in absorbance was directly proportional to the amount of 
formate in the original sample. 
A series of samples containing HPLC-grade water (instead of plasma) were run 
in conjunction with our analytical samples in order to allow us to account for any 
formate present in our reagents. This value was deducted from all analytical samples 
and spiked analytical samples prior to any calculations. In addition to controlling for 
reagent-based formate, we also accounted for any non formate-specific absorbance at 
500 nm. To account for absorbance at 500 nm that is not attributable to formate 
oxidation, we ran our assay in the absence of FDH until an initial plateau was reached. 
Following the addition of FDH, we calculated the increase in absorbance and used this to 
calculate the formate concentration. When our lab began using this assay we noted that, 
for similar concentrations of formate, aqueous standards reached a plateau faster than 
plasma samples. 
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Formate Formazan Dye 
NAD+ + H+ 
Formate 
Dehydrogenase Diaphorase 
NADH 
lodonitrotetrazolium 
(I NT) 
Figure 2.1 The two step enzymatic reaction involved in the enzymatic formate 
assay. For each formate oxidized to carbon dioxide, one molecule of INT was 
reduced to a formazan dye, the absorbance of which could be measured at 500 nm. 
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To eliminate any inconsistency, we decided that a plasma-based standard would be 
required. This was accomplished by spiking analytical samples with a known 
amount of formate. In such cases, a small amount of 10 mM sodium formate solution 
was added to acetonitrile. 
For each biological sample, two unique deproteinizations using HPLC-grade 
acetonitrile were conducted. One of these used unspiked acetonitrile, while the 
other used the spiked acetonitrile. The unspiked sample was run in triplicate, while 
the spiked sample was run alone. The averaged absorbance corresponding to the 
unspiked triplicates was subtracted from the spiked sample, to determine the 
absorbance corresponding to the known quantity of formate in the spike. On each 
microplate, we averaged all the spike absorbance values to calibrate the biological 
unknowns on each plate by way of a one-point calibration. We then solved for the 
unknown concentration in each normal analytical sample (based on the triplicates). 
Briefly, the procedure was as follows: Plasma was deproteinized by the 
addition of an equal volume of acetonitrile. Analytical samples were deproteinized 
with HPLC-grade acetonitrile; for spiked samples we used a mixture containing 95% 
HPLC-grade acetonitrile and 5% 10 mM sodium formate in HPLC-grade H20 
(voljvol). (This meant that each spiked sample had a concentration equivalent to 
the unknown analytical sample plus 0.25 mM formate.) Following two successive 
rounds of centrifugation (15000 x g, 10 min each, carrying over supernatant to 
second round), 50 11L of the clear supernatant was added to 200 11L of phosphate 
buffer cocktail (pH 7.4, 0.1 M) containing INT (1 mg/mL), NAD+(1 mgjmL) and 
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diaphorase (0.8 U/mL). INT was added first and stirred vigorously for one hour to 
ensure complete solubility. NAD+ and diaphorase were added subsequently; five 
minutes prior to initiation of the assay and stirred gently. After monitoring the 
absorbance (500 nm) for several minutes to ensure a plateau, 10 uL of FDH was 
added (15 U/mL). Low molecular weight contaminants in FDH were removed by 
passing the solution through a PD-10 desalting column before use in the assay. The 
absorbance was recorded for -2 hours, until a plateau was reached. A separate 
experiment determined that a linear response was obtained over the expected range 
of plasma formate concentrations expected from folate-replete and folate-deficient 
animals (up to 1 mM). 
2.6.2 Plasma formate concentration (GC-MS) 
A gas chromatograph in conjunction with a mass spectrometer (GC-MS) was 
used previously to measure the formate concentration in plasma samples ( 45). A 
known quantity of"heavy" sodium 13(-formate was added as an internal standard 
prior to derivatization by pentafluorobenzyl bromide (PFBBr). The unlabeled 
formate appeared at 226 mjz, while the heavy formate appeared at 227 mfz (1 amu 
higher). The ratio of peaks allowed for a determination of the plasma formate 
concentration. A standard curve was run with each assay, covering the expected 
formate concentration range for plasma in fol ate-replete and folate-deficient rats to 
confirm linearity in the assay. 
When we examined the peak 1 m/z above the regular formate peak (227 
mfz), it was important to bear in mind that there was naturally occurring 13C and 2H 
present beyond that which existed in the form of the 13C-formate internal standard. 
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These naturally occurring isotopes were present in both the derivitizing agent as 
well as in the endogenous formate sample. For a natural sample of formate, the 227 
mjz peak was 8.7% of the magnitude of the 226 mjz peak. 
2.6.3 13C-formate enrichment (GC-MS) 
Our studies of in vivo formate kinetics required the infusion of sodium 13C-
formate into the blood of an experimental animal. Periodic blood samples were then 
taken in order to monitor the ratio of the artificially-introduced heavy formate to 
endogenous formate produced by the animal. This posed a challenge; since sodium 
13C-formate was infused during the experiment, it could not also be used as the 
internal standard during analysis. 
To overcome this challenge, we introduced another simple carboxylic acid, 
(acetate) which is derivitized similarly to formate. Since acetate will occur naturally 
in biological samples (at varying concentrations), sodium 13C-acetate is introduced 
as the internal standard. The absolute formate concentration was determined by 
comparing the area under the peaks corresponding to regular formate and heavy 
acetate (226 mjz and 242 mjz respectively). Next, the ratio of artificially-
introduced heavy formate to endogenous formate is calculated as the ratio of peak 
areas for 227 mjz to 226 mjz. This is referred to as the tracer: tracee ratio or TTR. 
The assay was run by combining 15 !J.L of buffered internal standard (1mM 
sodium 13C-acetate in 0.5 MpH 8.0 phosphate buffer), 35 !J.L of plasma and 93 11L of 
PFBBr (100 mM in acetone). Following one minute ofvortexing in screw top glass 
vials, the samples are incubated for 15 minutes at 60° C. After 2 minutes on ice, 233 
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11L of hexane was added, followed by another minute ofvortexing. Two separate 
layers formed, the top consisting of an organic phase, and the bottom consisting of the 
aqueous phase and protein. The organic phase was carefully separated and run on the 
GC-MS (Thermo-Fisher Scientific 'Trace GC Ultra', carrier gas- 99.9997% pure 
methane,) using a splitlesss mode( ratio of 10, 1.5 minutes). The autosampler injects 
111L onto a 0.32 mm x 30m Agilent 08225 MS column. The run begins at 40° C, and 
increases by 15° C/min to 140° C, then increases at a rate of 50° C/min to 240° C. The 
full run lasts for 13.67 minutes. The MS uses EI-SIM mode(Electron Impact- Single Ion 
Monitoring), which exclusively monitors the mass fragments at 226, 227 and 242 mjz. 
These correspond to formate, 13C-formate and 13C-acetate respectively. 
2.7 Formate concentration in urine (proton NMR) 
Samples were thawed, vortexed and mixed 9:1 with 1.5 M phosphate buffer and 
finally syringe filtered through 0.451J.M filters (12). This mixture was inserted into 5 mm 
thin-walled 600 MHz-rated NMR tubes from Wilmad Glass. A coaxial insert (0.2 mM DSS 
in DzO) was loaded into the centre of each tube to calib rate and lock the signal. 256 
scans were run on each sample, using a Bruker A vance 600 MHz NMR spectrometer, 
with a TXI probe at a temperature of 298 K. The pulse program used a water-peak 
suppression program, producing a formate peak at 7.39 ppm relative to the DSS peak. 
The ratio of this peak to the DSS peak (appearing at 0 ppm) was proportional to the 
concentration of formate in the sample. Before running analytical samples, a standard 
curve was run on a series of standards to ensure linearity of the assay and allow for 
quantification of formate concentration. The use of the peak ratio (as opposed to 
absolute size of formate peak) accounts for any day-to-day variation of the assay. 
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2.8 Measurement of urinary creatinine 
Urinary creatinine was measured by the method ofYuen eta!.( 46) without 
any modifications. A Waters HPLC system was employed with a Hamilton PRP X200 
cation-exchange column. 
We normalized the urinary excretion of formate to the urinary excretion of 
creatinine. Creatinine is produced by the non-enzymatic breakdown of the body's 
pool of creatine. This occurs at a rate of 1. 7% of the total pool per day in 
humans( 47). The use of creatine as a marker of urine excreation assumes that it is a 
valid marker of GFR, and that the conversion of creatine to creatinine is the same 
under all physiological and pathological conditions. Since the creatine pool is 
maintained at a constant level, normalization to creatinine excretion allowed for an 
unbiased comparison of urinary metabolite excretion between experimental groups 
(such as from differences in the urine concentrating activity in kidney, or incomplete 
urine collections) ( 48) . 
2.9 Catalase activity 
Catalase activity was measured in liver samples according to the method of 
Aebi eta!. (34). Liver was flash frozen using clamps cooled in liquid Nz. Prior to 
analysis of experimental samples, we ensured that activity determinations were 
linear with respect to quantity of liver assayed and time of assay. 
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2.10 Homocysteine in plasma by HPLC 
Total homocysteine in plasma was analyzed by the method of Vester and 
Rasmussen( 49) with one modification. The internal standard was 8-
aminonapthalene-1,3,6-trisulfonic acid (ANTS) in place of mercaptopropionyl-
glycine. This was run on a Shimadzu HPLC system equipped with fluorescence 
detection on a Hypersil ODS (S~m) column. 
2.11 Statistics 
Simple statistical analyses, consisting of two data sets were, were conducted 
using two-tailed t-tests. A one-tailed t-test was used in those cases where similar 
previous data (either from the literature or from our own work) existed which could 
be used to predict a outcome. A significant result was accepted as Ps;O.OS. 
Experimental designs consisting of multiple groups were analyzed using one-
way ANOVAs, with pre-defined a priori comparisons against a control group. These 
multiple comparisons were conducted with Dunnett's test (which is designed for 
one-way ANOVAs in which several treatment groups have to be compared aginst a 
control group). The analysis of these is described in more detail as they arise. 
T-tests were conducted using Prism 3 for Windows. ANOVAs and multiple 
comparisons were conducted using R statistical programming language. 
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Chapter Three- Optimization of a coupled assay with formate dehydrogenase 
and diaphorase for determining plasma formate concentrations 
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3.1 Experimental Approaches 
The procedure for the measurement of plasma formate using the coupled-
enzyme system was aimed at increasing the sensitivity of the assay to formate, 
while reducing the background noise. Earlier work by our lab succeeded in 
modifying the assay from a traditional spectrophotometer setup (utilizing 3 mL 
cuvette) ( 44) to microplates. The major advantages of the microplate are the ability 
to read many samples in tandem, as well as the use of much less plasma. It was 
noted that even after completion of the assay, the absorbance would continue to rise 
in a linear fashion (this was termed "the creep"). 
The assay was optimized in a number of ways: 
1) We suspected the presence of a thiol additive in the enzyme preparation due to 
the smell. A literature search revealed that commercial preparations of FOH 
often include the use of the reducing agent dithiothreitol (OTT) (50). In order to 
eliminate any non-specific reduction of the tetrazolium dye due to OTT 
contamination, we ran the FOH preparation through a desalting column to 
remove small molecules. 
2) We determined the best type of tetrazolium dye for the assay. 
3) We determined the relative usefulness of an enzyme coupler (diaphorase) versus 
a chemical coupler to link the oxidation of formate to the reduction of the 
tetrazolium dye. 
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3.2 Results 
Buffered FDH solution was prepared (15 enzyme Ujml in 100 mM phosphate 
buffer, pH 7.4), and applied to a commercial PD-10 desalting column (purchased 
from GE Healthcare). The column works on the basis of size exclusion, with larger 
molecules (i.e. proteins) being eluted prior to smaller molecules. FDH was prepared 
according to the "gravity protocol" included with the columns. According to the 
manufacturer, the eluate retains 95%+ of the proteins while eliminating close to 
100% of any salts or small molecules. By Sigma Aldrich's definition, one enzymatic 
unit of FDH will oxidize 1.0 ~-tmole of formate to C02 per min in the presence of~-
NAD at pH 7.6 at 37 oc. 
Six samples were taken from a pool of rat plasma. They were deproteinized 
with acetonitrile and prepared as previously described (Section 2.6.1). Unfiltered 
FDH solution was applied to three of these samples, while gel-filtered FDH solution 
was used on the remaining three samples. The absorbance at 500 nm was 
monitored for 2 hours (one minute intervals). Results are given in Figure 3.1. Using 
the crude enzyme preparation (regular FDH), there was a continuous creep in the 
spectrophotometric reading so no result could be obtained. When small molecules 
were removed (gel-filtered FDH), the assay came to completion and a reliable 
reading could be obtained. 
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Figure 3.1. A comparison of a deproteinized plasma (with diaphorase, NAD+, and 
INT) after addition of both standard formate dehydrogenase (FDH) preparation and a 
FDH preparation gel-filtered using a PD-10 desalting column. 
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We conducted trials to determine if we could make the assay more sensitive 
by using a tetrazolium salt with a higher extinction co-efficient. A new tetrazolium 
dye, 2-( 4-iodophenyl)-3-( 4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium 
(marketed as water soluble tetrazolium-1; WST-1) was obtained from Dojindo 
Chemical (Japan) (51). WST-1 was tested in conjunction with the chemical coupler 
methoxy 5-methyl phenazinium methylsulfate (PMS) to couple the NADH to the 
reduction of the dye (the chemical coupler was used in place of diaphorase) . WST-1 
was specifically engineered to be readily water-soluble due to the addition of two 
hydrophilic sulfide groups. Both WST-1 and INT were tested on a series of aqueous 
formate standards (0, 16 and 24 11M) using desalted FDH. The INT /diaphorase 
system was run as per the previous procedure (Section 2.6.1). The WST-1/PMS 
buffer cocktail contained PMS (20 11g/mL) and WST-1 (1 mgjmL) in place of 
diaphorase and INT respectively. The NAD+ and phosphate buffer concentrations 
remained unchanged. These particular dye-reduction coupled systems were chosen 
from literature data ( 44, 51). 
Figure 3.2 shows a set of aqueous formate standards run with the two 
different dye-reduction systems. Although the absorbance is higher for the WST-
1/PMS dye-reduction system (due to a higher extinction co-efficient), there is the 
45 
(a) lodonitrotetrazolium (I NT) Dye with Diaphorase 
0.18 
-E 
s:::: 
0 
0 
10 0.12 
-Q) 
0 
s:::: 
m 
.c 
..... 0.06 0 
tn 
.c 
<( 
0.00 4---.---------r-----r---..----------r----. 
0 60 120 180 240 300 360 
Time( minutes) 
(b) Water Soluble Tetrazolium-1 (WST-1) Dye with PMS 
0.6 
-E 
s:::: 0.5 
0 
; 0.4 
-Q) 
0 
s:::: 
m 
.c 
..... 
0 
tn 
0.3 
0.2 
.c 
<( 0.1 
.;.: 
/ " 
! .... · 
-·· '( 
.·; 
E 
.. 
==··"" ...... 
... 
...... 
0. 0 +----r-----r---.--.----r-----, 
0 60 120 180 240 300 360 
Time( minutes) 
Figure 3.2. A comparison of a set of aqueous formate standards measured by two 
dye-reduction systems. 
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enormous drawback of the lack of a stable plateau. This is suggestive of NADH-
independent reduction of the dye. 
3.3 Analysis 
On the basis of the data shown in Figure 3.1, the desalted FDH was superior. 
The variability of replicate samples lessened, but more importantly, the stable 
plateau provided a reliable determination of formate. This cannot be said for the 
untreated FDH preparation as the absorbance continued to "creep". 
The data provided in Figure 3.2led us to choose the INT /diaphorase dye-
reduction system. The deciding factor in this case was that the WST -1/PMS system 
introduced a noticeable "creep", which would not permit accurate determinations of 
formate concentrations. Although the sensitivity of the WST -1/PMS system was 
superior, we could still detect concentration differences of -5 11M using the 
INT /diaphorase system. Given that the folate-replete animals have a baseline 
plasma formate concentration of -50 11M, and moderate folate deficiency increases 
this several-fold, we found that this sensitivity was quite suitable for our purposes. 
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Chapter Four- In vivo kinetics: rates of endogenous formate production in 
control and folate-deficient rats 
48 
4.1 Introduction 
In order to understand the differences in formate levels, we needed to be able 
to quantify the underlying rates of endogenous formate production. An analysis of 
plasma formate concentrations does not provide any information on the underlying 
kinetics of formate production. The use of isotopic tracers allowed us to determine 
the rate at which the rat produces formate (52). 
4.2 Stable Isotopic Tracers 
The biological molecule of interest is defined as the tracee (52). A 
corresponding tracer is employed, which is essentially the same molecule, but with 
one of its constituent atoms being an isotope with a higher or lower atomic weight 
than that which is naturally abundant. In our experiment, 13(-formate and 12(-
formate acted as tracer and tracee respectively. These two molecules are known as 
isotopomers and, although metabolically indistinguishable within the rat, differ by 1 
amu. On this basis, a gas chromatograph equipped with mass spectrometer (GC-MS) 
was used to differentiate between, and quantify, these formate isotopomers. A key 
assumption of this method is that the tracer be metabolically identical to the tracee. 
It was also important that the supply of exogenous tracer did not overwhelm the 
endogenous formate. If the artificially introduced formate pushed the concentration 
beyond normal physiological ranges, the experiment could not be considered to be 
representative of the natural state of the rat. 
Stable isotopic tracer methodology involves the infusion of the tracer into the 
rat, at a known and constant rate, for several hours. After some time, the tracer and 
tracee come to an equilibrium, due to the dilution of tracer by endogenously 
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produced formate. The next challenge is determining the extent of the whole body 
pool of tracee to which the tracer will have unhindered access. In order to track the 
movement of tracer mathematically, the organism is modelled as one or more 
compartments, within which the tracer and tracee can move freely. We have 
therefore made use of the single compartment model to describe the movement of 
tracer within the rat's endogenous formate pool. It is assumed that an equal tracer 
to tracee equilibrium is reached simultaneously throughout the entire organism. 
The tracer to tracee ratio ( TTR) is used to describe the steady-state isotopic 
enrichment. The confirmation of a plateau is based on a series of measurements of 
13C- and 12C- formate in plasma and, along with our rate of tracer infusion, allows us 
to calculate the endogenous rate of formate appearance (production) as follows: 
Ra = Rinf 
E , 
where Ra is the endogenous rate of appearance(!J.mol/hr) of formate in the rat, Rinf 
is the rate of infusion of sodium 13C- formate (!J.moljhr), and E is the plateau TTR 
(after equilibrium has been attained). This equation requires that both the TTR and 
metabolite concentration be stable. 
4.3 Procedure 
We determined the endogenous production rate of formate for six rats fed a 
folate-replete diet (Dyets #517802) and six rats fed a folate-deficient diet (Dyets 
#517777) for fifteen days. In preliminary experiments, we established that fifteen 
days provided a robust state of folate-deficiency, while still allowing the animal to 
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grow. Initial weights and specific growth rates (over final four days) are in Table 4.1. 
Figure 4.1 provides the growth curves for rats in this experiment. 
With the aid of previous work concerning the endogenous production of 
formate in sheep (53), we aimed for a steady-state TTR of -10%. The stock labelled 
sodium 13C-formate solution of 150 mM (300 mOsM) was diluted with 0.9% saline to 
give an infusate with a final concentration of 12.4 mM. This was filtered through a 
0.2 11m syringe filter before infusion. A 5 mL Hamilton Syringe and Harvard 
Microliter syringe pump (setting 6) provided -700 uL (8.8 11mol of sodium 13C-
formate) per hour without a priming dose. The rate of infusion was calculated to 
replace the fluid losses due to blood sampling. 
Rats were anesthetized with isoflurane in oxygen ( 4% for induction, 2% for 
maintenance) and catheters were surgically implanted into the femoral artery and 
contralateral femoral vein, and secured by silk suture. Catheters were produced by 
connecting a 4 em length of PE-SO tubing to 12 em of thinner PE-10 by heat 
adhesion. The sodium 13C-formatejsaline solution was infused via the venous 
catheter, and blood samples were drawn from the femoral arterial catheter. 200 11L 
of blood was taken at zero time and the infusion started. Thereafter, 200 11L of blood 
was taken in 20 minute intervals for 1.5 hours. After each sampling, the arterial 
catheter was flushed with heparinized saline (100 U/mL). 
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Table 4.1. Initial weights and specific growth rates (over final four days of 
experiment) of rats fed folate-deficient or folate-replete Dyets Inc. amino acid-
defined diet (#517777 and #517802 respectively). Values are given as: mean (S.D.) 
and n=6. There were no significant differences between the folate-replete and 
folate-deficient group (p <0.05) on the basis of a two-tailed t-test. 
Folate-Replete Folate-Deficient 
Initial Weight (g) 67 ( 4.1) 65(4.4) 
SGR 0.035 (0.0078) 0.032 (0.0078) 
(g gained •d·l •g body wieght-1) 
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Figure 4.1. Average weights of rats fed either the folate-replete (cat. #517802) or 
folate-deficient (cat. #517777) version of of the Dyets Inc. amino acid-defined diet 
for 15 days. Error bars indicate standard deviation for the weight of rats and n=6. 
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4.4 Results 
Rats undergoing a constant infusion of sodium 13C-formate reached a steady-
state plateau of isotopic enrichment within one hour (e.g. Figure 4.2 and 4.3). There 
were no obvious differences between the groups in the time needed to reach a plateau. 
This resulted in a TTR of -6% for rats fed a folate-replete diet (Dyets cat. #517808), and 
-10% in rats given a folate-deficient diet (Dyets cat. #517777) (Table 4.2). This 
corresponds to an endogenous formate production rate of75 11moljhrj100 g in folate-
replete rats, with folate-deficient rats at about half this rate at 45 11moljhr /100 g (Figure 
4.4). 
Endogenous formate production can be compared to the total dietary intake of 
potential formate precursors by measuring daily food intake and using knowledge of 
catabolic pathways capable of yielding formate and one carbon-bearing folates (Table 
4.3). We found that endogenous formate production accounted for 35% of total 
ingested 1C precursor potential in folate-replete animals, and 20% in folate-deficient 
animals (Figure 4.5). However, this estimate assumes that all of the dietary amino acids 
are available for catabolism. This is not so as our rats continued to grow. We estimated 
amino acid utilization for net protein synthesis from knowledge of the protein content 
of the whole male Sprague-Dawley rat (54), the amino acid profile of whole rat protein 
(55) and the specific growth rate of rats over the final four days of the experiment. 
These rats will lay down 6g of new tissue in 24 hours, of which 1.194 g will be 
protein. We therefore calculated the quantity of each of methionine, glycine, serine, 
histidine and tryptophan that will be incorporated into net protein. This was subtracted 
from the quantity of each amino acid ingested to provide a more accurate estimate of 
the quantity of each amino acid available for formate production. 
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Figure 4.2. Typical t imecourse for plasma formate concentration and TTR over -2 
hours for a rat undergoing a constant infusion of sodium 13( -formate (8.8 11molj hr). 
The plasma concentration remains constant, and isotopic equilibrium is reached 
after one hour. This particular rat was fed a fo late-replete version of the Dyets Inc. 
amino acid-defined diet (cat. # 517802) for 15 days. 
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Figure 4.3. Typical timecourse for plasma formate concentration and TTR over -2 
hours for a rat undergoing a constant infusion of sodium 13C-formate (8.8 11mol/hr). 
The plasma concentration remains constant, and isotopic equilibrium is reached 
after one hour. This particular rat was fed a folate-deficient version of the Dyets Inc. 
amino acid-defined diet (cat. #517777) for 15 days. 
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Table 4.2. TTR (13C-formate to 12C-formate), plasma formate concentration and rate 
of endogenous formate production (per 100g rat body weight) compared between 
folate-replete and folate-deficient rats having undergone a constant infusion of 
sodium 13C-formate (8.8 11moljhr) after attaining isotopic equilibrium. Values given 
as: mean (S.D) for each group of rats and n=6. Different superscripts indicate a 
signficant difference (P:s;O.OS) by two-tailed test, except for plasma formate 
concentration by one-tailed t-test. 
Plateau TTR Plasma formate 
concentration 
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Figure 4.4. Comparison of rates of endogenous formate production between animals 
fed either a folate-deficient (Dyets Inc. #5 17777) or folate-replete (Dyets Inc. 
#5 17802) diet for 15 days. Bars indicate the average of the groups; error bars are 
standard deviation (n=6). Statistics by two-tailed t-test. Three asterisks indicate 
P~0.001 by two-tailed t-test. 
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Table 4.3. Total1C potential from average daily consumption (23 g for a 200g rat) of Dyets Inc. amino acid-defined diet. This is 
based on quantities of the 1C precursors consumed (column 3), and number of one-carbon groups, which can be maximally 
provided by each molecule during catabolism (column 4). 
1 2 3 4 5 6 
Precursor gjkg diet mmols/kg Multiplier 1C Potential/kg diet 1C Potential based on daily diet 
diet intake * 
Histidine 3.3 21.3 1 21.3 0.49 
an 1.74 8.5 1 8.5 0.20 
Methionine 8.2 55.0 1 55.0 1.26 
ne 23.3 310.4 1 310.4 7.14 
Serin 3.5 33.3 2 66.6 1.53 
Choline Chloride 2 14.4 4 57.6 1.32 
Potential 1C Precursors in 1 KG diet 
Potential1C Precursors- average daily food intake (mmol) 
*There was no difference between the food intake of the folate-replete and folate-deficient rats, so that our estimate of dietary 
1C group potential is identical for both groups. 
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Figure 4.5. Actual endogenous formate production compared to ingestion of potential 
formate precursors. Animals were fed either a folate-deficient (Dyets Inc. #517777) or 
folate-replete (Dyets Inc. #517802) diet for 15 days, then given a constant infusion of 
sodium 13C-formate (8.8 !J.moljhr). Bars indicate the average of the group, error bars 
are standard deviation (n=6). One asterisk indicates P=:;0.05 by two-tailed t-test. 
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We calculated that formate production amounts to 44% of the maximal possible 
one-carbon units available from the diet (subtracting that used for protein synthesis) in 
the folate-replete rats and 24% in the folate deficient rats (Table 4.4). 
Figure 4.6 compares the plasma formate concentration to the hourly rate of formate 
production in folate-replete and folate-deficient animals. There is a remarkable 
differentiation between the responses of the two groups of animals. There was a positive 
relationship between both parameters in the folate-replete animals. However, in the 
folate-deficient animals, the highest levels of formate were accompanied by reduced rates 
of endogenous formate production. 
4.5 Analysis 
The positive correlation between formate concentration and formate production 
rates suggests that in this situation, the plasma formate concentration is largely 
determined by the rate of formate production. In folate-deficient rats, the opposite is 
found; a higher plasma formate concentration is associated with a lower rate of 
endogenous formate production. This inverse relationship leads us to conclude that folate-
deficient rats have a significant decrease in both the production and removal of free 
formate. 
The comparison of actual endogenous formate production to the ingested potential 
1C precursors leads us to conclude that formate production may be a major, though 
ignored, motif for some of the dietary 1C precursors. After accounting for the amino acids 
required for net protein synthesis, we find that formate production accounts for nearly half 
of the available 1C precursor in the folate-replete rat, and close to a quarter in the folate-
deficient rat. 
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Table 4.4. Estimation of quantity of known individual formate precursors that are required for net protein synthesis. 
Amino 
Acid 
Molar proportion of Quantity of amino acid 
rat whole body used for net protein 
protein (54) synthesis 
0.0168 0.195 
0.0140 0.161 
0.0220 0.253 
0.1611 1.853 
0.0523 0.605 
62 
Quantity of amino acid or 
choline provided in diet 
(mmol/24h/200g rat) 
0.489 
0.196 
1.264 
7.139 
1.532 
Quantity of amino acid or 
choline not used for net 
0.294 
0.035 
1.011 
5.286 
0.927 
24.4% 
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Figure 4.6. Comparison of the relationship between plasma formate con centra 
the hourly rate of formate production rats fed either a folate-deficient (o) or fo 
replete (~) diet for 15 days (n=6) . Each point represents a single animal. The li 
were fitted by least squares regression. 
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Chapter Five - Supplementation studies with dietary 1C precursors of the 
formate pool 
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5.1 One-carbon precursor supplementation I 
5.1.1 Introduction 
The first supplementation experiment with dietary one-carbon precursors was 
based on the idea that in those animals with elevated urinary formate excretion and 
plasma formate concentrations, the elevated formate must arise as a result of 
increased formate production from established one-carbon precursors. These 
precursors were discussed in the introduction, and are mainly derived from the 
catabolism of certain amino acids and choline. Equal numbers of rats were fed either a 
folate-replete or folate-deficient diet, based on the purified diet provided by Dyets Inc. 
(cat. #517802 and #517777 respectively). This trial ran for 15 days, with specific 1C 
precursor-supplemented diets being provided on the final 3 days (see details of diet 
modification in Appendix D). Animals were obtained in cohorts of fifteen, as they 
became available from the breeding stock. The initial weights, and specific growth 
rates (over the final four days) of rats fed each diet are provided in Table 5.1. Growth 
curves for rats fed the unsupplemented versions of the folate-replete and folate-
deficient versions of the Dyets Inc. composition during this experiment are provided in 
Figure 5.1. 
\ 
A distinguishing feature of this diet is that the protein content is derived from 
individual L-amina acids, allowing for a highly accurate measurement of the intake of 
each precursor. Precursors of interest included the amino acids tryptophan, glycine, 
serine, methionine and histidine. The non-amino acid choline and two of its 
metabolites DMG and sarcosine were also investigated. 
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Table 5.1. Initial weights and specific growth rates (for final four days) of rats fed 
control versions of the folate-replete and folate-deficient Dyets Inc. L-amino acid-
defined diet (#517802 and #517777 respectively). Values are given as: mean (S.D.) for 
each group of rats and n=6. Different superscripts indicate that a significant difference 
exists between the folate-replete and folate-deficient groups (p <0.05) on the basis of a 
two-tailed t-test. 
Folate-Replete Folate-Deficient 
Initial Weight (g) 70.5 (9.2) 70.0 (8.2) 
SGR 0.051 (0.0065) 3 0.046 (0.0076)b 
(g gained •d-1 •g body wieght-1) 
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Figure 5.1. Average weights of rats fed either the fo late-replete (cat. #517802) or 
folate-deficient (cat. # 517777) version of of the Dyets Inc. L-amina acid-defined diet 
over the course of 15 days. Error bars indicate standard deviation of rat weights and 
n=6. 
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For supplemented experimental groups, we doubled the baseline diet 
concentration of the precursor of interest. Glycine was present in the highest quantity 
and so was simply doubled. All supplementations were isonitrogenous. As such, for 1C 
precursors present in lesser quantities, the molar difference was made up by extra 
alanine. 
In order to ensure that the extra alanine did not affect results, an all-alanine 
supplementation group was also run. Due to the fact that the Dyets Inc. diet is pre-
mixed, the mass of the whole diet was reduced according to the combined mass of 1C 
precursor and alanine added. These additions accounted for less than 1% of the overall 
mass, and as such all other components were reduced by this amount. 
We staggered each supplementation group over several cohorts. The folate-
replete/folate-deficient versions of the diet were staggered in the same way. In 
addition, we ran an early group of unsupplemented controls as well as a later group of 
unsupplemented controls, at both the folate-replete and folate-deficient levels in order 
to ensure comparability. These early and late unsupplemented controls were 
compared (using a separate t-test at each folate level) . We used a one-way ANOVA to 
compare the folate- replete animals and another one-way ANOVA to compare the fol ate-
deficient animals. Each 1C precursor supplementation group was compared to its 
respective control. In effect, this meant that the folate-defici ent analysis was separate 
from the folate-replete analysis. With the exception of the unsupplemented controls 
(n=6), all experimental groups were run at a sample size of n=3. Since catalase may 
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clear excess formate rapidly, we compared liver catalase activity between control 
folate-replete and control folate-deficient rats. 
5.1.2 Results 
The plasma formate concentration of rats fed a folate-replete version of the 
Dyets Inc. L-amino acid-defined diet (#517802) supplemented with a variety of dietary 
1C precursors is provided in Figure 5.2. Relative to the unsupplemented folate-replete 
control group, extra glycine, histidine, serine, and tryptophan all increased the plasma 
formate concentration significantly. Figure 5.3 provides similar information for 
animals fed the supplemented Dyets Inc. folate-deficient diet (#517777). In this case 
there was no significant difference between the formate levels of the different groups. 
This may be due to high variability. It is worth noting that, although only two glycine-
supplemented folate-deficient rat plasma samples were successfully obtained, the 
mean is nearly half that of the unsupplemented folate-deficient control. 
Figures 5.4 and 5.5 show the 24 hour excretion of urinary formate, normalized 
to creatinine excretion, for rats fed either the folate-replete or deficient diets and 
supplemented with dietary 1C precursors. Among the rats fed the folate-replete diet 
only serine supplementation resulted in significantly elevated formate excretion, while 
in the folate-deficient supplementations only DMG supplementation resulted in 
significantly elevated formate excretion. 
Catalase, an enzyme capable of large-scale catabolism of formate, was equally 
active in rats fed either folate-deficient or folate-replete diets (Figure 5.6). 
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Figure 5.2. Plasma formate level for rats fed a folate-replete L-amino acid-defined diet 
(Dyets Inc. #517802) for 15 days, supplemented with extra one-carbon precursors for 
the final 3 days. Specific supplementations are described in Appendix D. Bars 
represent the mean of the group; error bars are standard deviation. The 
unsupplemented folate replete group (n=6) is solid green; supplemented groups are 
shaded green (n=3). The corresponding control for animals fed a folate-deficient diet is 
shown as solid red (n=6) to allow for comparison. Statistics were carried out by one-
way ANOVA with comparisons against the folate-replete unsupplemented control and 
alanine groups (one asterisk indicates P$0.05, two asterisks indicates P$0.01, three 
asterisks indicates P$0.001). Abbreviations: FD- unsupplemented folate-deficient, FR 
- unsupplemented folate-replete. 
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Figure 5.3. Plasma formate level for rats fed a folate-deficient L-amina acid-defined diet 
(Dyets Inc. #517777) for 15 days, supplemented with extra one-carbon precursors for 
the final 3 days. Specific supplementations are described in Appendix D. Bars 
represent the mean of the group; error bars are standard deviation. The 
unsupplemented fo late-deficient group (n=6) is solid red; supplemented groups are 
shaded red (n=3, except glycine n=2). The corresponding control for animals fed a 
folate-replete diet is shown as solid green (n=6) to allow for comparison. Statistics 
were carried out by one-way ANOVA with comparisons against the folate-deficient 
control and alanine groups; no significant differences were found. Abbreviations: FD -
unsupplemented fo late-deficient, FR- unsupplemented folate-replete. 
71 
::::-
0 
E 
15.0 
:::: 
0 12.5 
E 
-(I) 
1: 
1: 10.0 
+l 
ns 
~ (.) 
:! 
ns 
E 
... 
0 
u. 
~ 
ns 
1: 
'i: 
:J 
7.5 
5.0 
2.5 
0.0 
* 
FD FR Gly His Trp Met Ala Ser Chol Sarc DMG 
Precursor Addition 
Figure 5.4. 24 hour formate excretion, normalized to creatinine excretion, in the urine 
of rats fed a folate-replete L-amina acid-defined diet (Dyets Inc. #517802) for 15 days, 
supplemented with extra one-carbon precursors for the final 3 days. Specific 
supplementations are described in Appendix D. Bars represent the mean of the group; 
error bars are standard deviation. The unsupplemented folate replete group (n=6) is 
solid green; supplemented groups are shaded green (n=3). The corresponding control 
for animals fed a folate-deficient diet is shown as solid red (n=6) to allow for 
comparison. Statistics were carried out by one-way AN OVA with comparisons against 
the folate-replete control and alanine groups (one asterisk indicates P~O.OS). 
Abbreviations: FD- unsupplemented folate-deficient, FR- unsupplemented folate-
replete. 
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Figure 5.5. 24 hour formate excretion, normalized to creatinine excret ion, in the urine 
of rats fed a folate-deficient L-amino acid-defined diet (Dyets Inc. #517777) for 15 
days, supplemented with extra one-carbon precursors for the final 3 days. Specific 
supplementations are described in Appendix D. Bars represent the mean of the group; 
error bars are standard deviation. The unsupplemented folate-deficient group (n=6) is 
solid red; supplemented groups are shaded red (n=3). The corresponding control for 
animals fed a folate-replete diet is shown as solid green (n=6) to allow for comparison. 
Statistics were carried out by one-way ANOVA with comparisons against the folate-
replete control and alanine groups (one asterisk indicates P:s;O.OS). Abbreviations: FD-
unsupplemented fo late-deficient, FR- unsupplemented folate-replete. 
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Figure 5.6. Catalase activity in the livers of rats fed either a folate-deficient Dyets (cat. 
#517777) or folate-replete Dyets(cat. #517802) L-amina acid-defined diet for 15 days. 
Activity is defined as the mmoles of hydrogen peroxide converted to oxygen and water 
per minute per gram of liver protein. Bars represent the mean of each group, error bars 
are standard deviation. Means were compared using a two-tailed t-test. 
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5.2 Establishing another model for folate-deficiency in the rat. 
5.2.1 Selecting a diet 
The differences seen in both plasma formate levels and urinary formate excretion 
were in line with what we expected in folate-deficient rats compared to folate-replete 
rats(12). Despite this, we were concerned by the unusually high quantity of glycine present 
in the Dyets Inc. composition (as compared to the American Institute of Nutrition's 
recommendations for experimental rodent diets) due to its ability to generate 1C 
groups( 41). We decided to compare the effect of casein-based AIN-93G diet against the 
amino acid-defined diet from Dyets Inc. in a side-by-side experiment. 
Appendix 8 provides a comparison of the amino acid composition of the AIN-93G-
based diet and the Dyets Inc. diet. The detailed compositions of both diets are provided in 
Appendix C. MP Biomedical offers a high-nitrogen casein which is purified in order to 
minimize vitamin content. This was used to create the AIN-93G-based diets. The 
opportunity arose to send the Dyets compositions to Dr. Mcfarlane (of Health Canada) for 
folate analysis of the folate-replete and folate-deficient versions, the results of which are 
also included in Appendix C. A microbiological assay was used because it is able to 
quantify all variants of folate/folic acid regardless of the length of glutamate tail or 
oxidation state. 
We conducted a study to compare the two diets. Four diet groups were established 
with four rats in each group. The initial weights are provided in Table 5.2. The diet groups 
were Dyets folate-replete, Dyets fo late-deficient, AIN-93G folate-replete, and AIN-93G 
folate-deficient. After 9 days, 2 animals from each subgroup were sacrificed and blood was 
collected and plasma prepared. After 18 days, the remaining 8 animals were 
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Table 5.2. Initial weights for rats fed either the folate-replete or fo late-deficient form of 
a commercially produced amino acid-defined diet (Dyets Inc.), or on the AIN-93G-
based diet. 4 rats began each of the 4 diets. Mean weights are given with standard 
deviations in parentheses. No significant differences were found using two-tailed t-
tests. 
Dyets Inc. AIN-93G 
Folate Status Deficient Replete Deficient Replete 
Initial Weight 68.3 (3.4) g 72.3 (5.30) g 71.8 (7.8) g 70.5 (6.7) g 
(g) 
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sacrificed, and blood was sampled and plasma collected. Plasma homocysteine and 
formate were measured in order to establish folate-deficiency in each group. Statistics 
were not determined the sample size was too small (n=2). Figure 5.7 provides the 
growth curves for rats fed each of the four diets over the course of 18 days, which show 
that by the end of the 18 day trial, the rats fed an AIN-93G-based diet weighed slightly 
more than those rats fed the Dyets Inc. diet. 
A comparison of the plasma formate concentrations between rats fed either a 
Dyets Inc. or AIN-93G-based diet showed that neither diet induced an appreciable level 
of folate-deficiency after 9 days (Figure 5.8). Both diets (in both the folate- replete and 
folate-deficient forms) resulted in a plasma formate concentration of -50 IJ.M. After 18 
days, the folate-replete animals showed similar formate levels as those recorded at 9 
days; however the plasma formate concentrations of animals fed the folate-deficient 
versions of either diet nearly tripled. We concluded that neither diet has a clear 
advantage in inducing folate-deficiency based on these data. 
Figure 5.9 shows that after 9 days, the folate-deficient version of both diets 
resulted in a plasma homocysteine concentration twice that of the respective folate-
replete diets. After 18 days, the AIN-93G-based diet produced a two-fold increase in 
plasma homocysteine concentration over the control diet. By comparison, the Dyets 
(#517777) folate-deficient diet produced a six-fold increase in plasma homocysteine 
over the control diet (#517802) at 18 days. 
The preceding results indicate that both diets could have been used to induce a 
moderate folate-deficiency within similar periods of time. AIN-93G did provide two 
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Figure 5.7. Average weights of rats fed either a folate-replete or folate-deficient version 
of either an AIN-93G-based diet or amino acid-defined diet produced by Dyets Inc. (cat. 
#517777- folate-deficient, Cat. #517802- folate-replete) for up to 18 days. The data 
are the average of two animals per category. 
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Figure 5.8. Plasma formate concentration (y-axes; uM) of rats fed either an AIN-93G-
based or amino acid-defined Dyets Inc. (Cat. #517777, 517802) diet for either 9 or 18 
days (both normal and folate-deficient varieties of each were tested). The data are the 
averages of two animals per category. 
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Figure 5.9. Plasma homocysteine concentration (y-axes; uM) of rats fed either an AIN-
93G-based or amino acid-defined Dyets Inc. (Cat. #517777, 517802) diet for either 9 or 
18 days (both normal and folate-deficient varieties of each were tested). The data are 
the averages of two animals per category. 
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key advantages compared to Dyets. One of our primary goals was to supplement the 
chosen diet with extra dietary 1C precursors, a process which would be simpler with a diet 
that we produce (AJN-93G). Since we prepare this diet from stock ingredients, we could 
increase or decrease specific components as necessary, an option not available with Dyets, 
because the composition arrives pre-mixed. Secondly, we were concerned by the high 
levels of glycine in the Dyets mixture (-20% of total amino acids by mass), a level that was 
several fold-higher than that recommended by the American Institute for Nutrition ( 41). 
5.2.2 Establishing an experimental timescale 
Following this comparison, we began studies on folate-deficiency using rats fed the 
AJN-93G-based diet. The initial objective was to determine the time course for induction 
of mild folate-deficiency. We set up a feeding study using AIN 93G diet (folate-replete and 
folate-deficient) for 30 days. At successive six day intervals, we sacrificed 6 rats (3 from 
each group) and measured the concentrations of formate and homocysteine in the plasma, 
as well as the daily excretion of formate in the urine. 
Growth curves for both groups of rats are provided in Figure 5.10. Both the folate-
replete and folate-deficient versions of the AIN-93G-based diets resulted in a consistent 
and comparable increase in weight. 
Dietary folate status had no effect on plasma formate concentration after 6 days 
(see Figure 5.11). We saw some difference in plasma formate concentration between 
groups after 12 days and 24 days, although there was large within-group variance. Plasma 
formate concentration was significantly different at 18 days and 30 days. 
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Figure 5.10. Average weights of rats fed either the folate-replete or folate-deficient 
AIN-93G-based diet for up to 30 days. Sample size decreases with increasing time( days 
0-12; n=12, days 14-18; n=9, days 20-24; n=6, days 26-30; n=3). Error bars indicate 
standard deviation. 
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Figure 5.11. Plasma formate levels in rats fed an AIN-93G-based diet with and without 
folic acid for up to 30 days (n=3). Bars represent the mean of each group, error bars are 
standard deviation. One asterisk indicates statistical significance of P:sO.OS, two 
asterisks indicates P:s;O.Ol by one-tailed t- test. Each test for significance compares the 
fo late-deficient rats against a group of rats fed a fo late-replete diet for the same 
number of days. 
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Plasma homocysteine was not affected by folate status until 18 days of feeding 
(Figure 5.12), when the concentration in folate-deficient rats increased to twice that of 
the folate-replete rats. Homocysteine remained elevated after 24 or 30 days, although 
the within-group variance becomes larger. 
24 hour formate excretion in the urine is shown in Figure 5.13. Although 
formate excretion in folate-deficient animals appears to begin to exceed that of the 
corresponding folate-replete rats after 12 days, the only comparison where significance 
is achieved is at 18 days. 
One-tailed t-tests were used in each of the above analyses, as it had already been 
established that under conditions of folate-deficiency, elevations above baseline would 
be observed in plasma formate, urinary formate excretion and plasma homocysteine 
(12). 
Minimizing variance within an experimental treatment (small standard 
deviation) is important due to the fact that it allows for smaller experimental groups 
and consequently less animal usage. We would naturally choose the shortest viable 
timescale in order to economize our resources. Considering these points and the data, 
we selected 18 days as the ideal length of time to induce mild folate deficiency in rats 
fed an AIN-93G-based diet. 
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Figure 5.12. Plasma homocysteine levels in rats fed an AIN-93G-based diet with and 
without folic acid for up to 30 days (n=3). Bars represent the mean of each group, 
error bars are standard deviation. One asterisk indicates statistical significance of 
P:50.05, three asterisks indicates a significance of P:50.001 by one-tailed t- test. Each 
test for significance compares the fo late-deficient rats against a group of rats fed a 
fo late-replete diet for the same number of days. 
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Figure 5.13. 24 hour formate excretion in urine, normalized to creatinine excretion, for 
rats fed an AIN-93G-based diet with and without folic acid for up to 30 days (n=3). Bars 
represent the mean of each group, error bars are standard deviation. One asterisk 
indicates statistical significance of P::;O.OS by one-tailed t- test. Each test for significance 
compares the folate-deficient rats against a group of rats fed a folate-replete diet for 
the same number of days. 
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5.3 One-carbon precursor supplementation II 
5.3.1 Objectives 
A second one-carbon precursor supplementation experiment was carried out in 
which a number of modifications were made. The principal difference was that a 
casein-based diet (AIN-93G) was employed in place of the Dyets Inc. diet. The animals 
were fed for 18 days, and were placed on individual one-carbon precursor 
supplemented diets for the final five days (rather than three). All dietary lC precursors 
studied were increased by 46 mmol per kilogram of prepared diet. This amount of 
supplementation was chosen to provide a 50% increase in the dietary level of serine. A 
corresponding mass reduction in corn starch (the most abundant ingredient in the 
diet) offset this addition. Details of the composition of the AIN-93G-based diets are 
provided in Appendix C, and modifications resulting from lC precursor 
supplementation to these diets are in Appendix E. We did not supplement with 
sarcosine or DMG since they are not provided in the diet, but rather are produced in the 
body through the catabolism of choline. 
During the first lC precursor supplementation study we found that there 
appeared to be greater variance in the plasma and urine formate concentrations in the 
folate-deficient rats. We addressed this by assigning a greater number of our available 
animals to the folate-deficient groups. 90 male Sprague-Dawley weanling rats arrived 
in 2 cohorts (A&B). Cohort A consisted of 50 animals, while Cohort 8 contained 40 
animals. The distribution of cohorts, and supplemented diet assignments are provided 
in Table 5.3. 
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Table 5.3. Organization of the 18 day, one-carbon precursor supplementat ion study 
using AIN -93G-based d iet (carried out using two cohorts of animals) . For each 
supplementation group (or unsupplemented control), 6 rats were given a fo late-
deficient diet, and 4 rats received the corresponding folate-replete diet. Cohorts A and 
8 are shown below. Both cohorts were combined to form the third table which 
represents the overall experimental design. 
Folate Status of 
Diet 
Folate Status of Diet 
Folate Status of Diet 
Precursor Supplementation Cohort A (n=SO) 
Ctrl A Serine Tryptophan Alanine Glycine 
Replete 4 4 4 4 4 
Deficient 6 6 6 6 6 
Precursor Supplementation Cohort 8 (n=40) 
Ctrl 8 Histidine Methionine Choline 
Replete 4 4 4 4 
Deficient 6 6 6 6 
Combined Cohorts (n=90) 
Ctrl Ala Met Gly Ser Trp His Choline 
Replete 8 4 4 4 4 4 4 4 
Deficient 12 6 6 6 6 6 6 6 
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We also compared the plasma homocysteine levels of choline-supplemented 
animals with other one-carbon precursor supplemented rats as well as 
unsupplemented rats, within the folate-replete and folate-deficient groups. This 
analysis was of interest because betaine (a catabolite of choline), in concert with 
betaine: homocysteine methyltransferase, can remethylate homocysteine to produce 
methionine, effectively lowering the baseline homocysteine concentration. 
The combined experimental design served as the basis of the statistical analysis 
for the plasma formate concentration and urinary formate excretion. During our 
planning stages, and in consultation with a statistician (Dr. David Schneider, Memorial 
University, Canada), we devised a series of a priori comparisons, in which each 
supplementation group was compared against its appropriate unsupplemented control 
(either at the folate-replete or folate-deficient level). For the purposes of this analysis, 
we treated the alanine supplementation group as part of the unsupplemented control 
on the grounds that it lacks any additional one-carbon potential. T -tests were used to 
determine that it did not differ from the unsupplemented controls of either the folate-
replete or folate-deficient groups. The initial weights, and specific growth rates (over 
final four days) of rats fed each diet are provided in Table 5.4. Growth curves for rats 
fed the unsupplemented versions of the folate-replete and folate-deficient versions of 
the AIN-93G-based diet during this experiment are provided in Figure 5.14. 
89 
Table 5.4. Initial weights and specific growth rates (SGR) (over last four days of the 
experiments) of rats fed unsupplemented versions of the folate-deficient (n=12)and 
folate-replete (n=8) AIN 93G-based diet. Values are given as: mean (S.D.). Different 
superscripts indicate that a significant difference exists between the folate-deficient 
and folate-replete group (p <0.05) on the basis of a two-tailed t -test. 
Folate-Replete Folate-Deficient 
Initial Weight (g) 62 (5.3) 58 (6.4) 
SGR (g d-1 g-1) 0.050 (0.0037)a 0.043 (0.0057)b 
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Figure 5.14. Average weights of rats fed either the fo late-replete (n=8) or folate-
deficient (n=12) version of an AIN-93G-based diet over the course of 18 days. Error 
bars indicate standard deviation of rat weights. 
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5.3.2 Results 
The plasma formate concentration of animals fed either a folate-replete or 
folate-deficient AIN-93G-based diet supplemented with individual dietary formate 
precursors is shown in Figures 5.15 and 5.16 respectively. Among the folate-replete 
rats, only those given extra histidine showed a significantly increased plasma formate 
concentration. Among those rats given the folate-deficient diet, only supplementation 
with choline significantly increased plasma formate concentration; extra glycine 
significantly decreased plasma formate concentration. 
No significant changes were noted in the urinary formate excretion of animals 
ingesting the folate-replete diet together with extra dietary formate precursors (Figure 
5.17). Those folate-deficient animals given extra choline or tryptophan excreted 
significantly more formate in the urine than did the unsupplemented folate-deficient 
control (Figure 5.18). 
Choline supplementation did not decrease plasma homocysteine compared to 
other supplementations/control in the folate-replete grouping (Figure 5.19). However, 
a significant decrease in plasma homocysteine was noted in fol ate deficient animals 
supplemented with extra choline(Figure 5.20). Choline was of specific interest in the 
context of plasma homocysteine because its metabolite betaine can be used by BHMT 
to create methionine from homocysteine, thereby lowering total plasma homocysteine 
levels. The other amino acids, lacking this ability, were grouped together for the 
purposes of this particular analysis. 
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Figure 5.15. Plasma formate concentration for rats fed a folate-replete, AIN-93G-based 
diet for 18 days, supplemented with an extra 46 mmoljkg diet of individual one-carbon 
precursors for the final 5 days. Bars represent the mean of a group; error bars are 
standard deviation (n=8 control, n=4 supplemented groups). One asterisk indicates 
P:s:O.OS. Statistics were carried out by one-way ANOVA with comparisons of each 
experimental group against the combined unsupplemented control plus alanine 
groups. 
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Figure 5.16. Plasma formate concentration for rats fed a folate-deficient, AIN-93G-
based diet for 18 days, supplemented with an extra 46 mmoljkg diet of individual one-
carbon precursors for the final 5 days. Bars represent the mean of a group; error bars 
are standard deviation (n=12 control, n=6 supplemented groups). One asterisk 
indicates P~0.05, three asterisks indicates P~0.001. Statistics were carried out by one-
way AN OVA with comparisons of each experimental group againstthe combined 
unsupplemented control plus alanine groups. 
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Figure 5.17. 24 hour formate excretion, normalized to creatinine excretion, in the urine 
of rats fed a folate-replete, AIN-93G-based diet for 18 days, supplemented with an extra 
46 mmolf kg diet of individual one-carbon precursors for the final 5 days. Bars 
represent the mean of a group; error bars are standard deviation (n=8 control, n=3-4 
supplemented groups). No significant differences were found. Statistics were carried 
out by one-way ANOVA with comparisons of each experimental group against the 
combined unsupplemented control plus alanine groups. 
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Figure 5.18. 24 hour formate excretion, normalized to creatinine excretion, in the urine 
of rats fed a folate-deficient, AIN-93G-based diet for 18 days, supplemented with an 
extra 46 mmoljkg diet of individual one-carbon precursors for the final 5 days. Bars 
represent the mean of a group; error bars are standard deviation (n=11 control, n=4-6 
supplemented groups). Three asterisks indicate P:s:O.OOl. Statistics were carried out by 
one-way ANOVA with comparisons of each experimental group against the combined 
unsupplemented control plus alanine groups. 
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Figure 5.19. Plasma homocysteine concentration in rats fed a folate-replete, AIN-93G-
based diet for 18 days (supplemented with an extra 46 mmoljkg diet of individual one-
carbon precursors for the final 5 days). The AA precursors group consisted of all the 
supplemented animals except for those provided with extra choline. Bars indicate 
mean; error bars are standard deviation (n=5 control, n=14 AA precursors, n=4 
choline). Statistics were carried out by one-way AN OVA with comparisons against the 
unsupplemented control. 
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Figure 5.20. Plasma homocysteine concentration in rats fed a folate-deficient AIN 93G 
diet for 18 days (supplemented with an extra 46 mmolfkg diet of individual one-
carbon precursors for the final 5 days). The AA precursors group consisted of all the 
supplemented animals except for those provided with extra choline. Bars indicate 
mean; error bars are standard deviation (n=7 control, n=17 AA precursors, n=6 
choline). One asterisk indicates P~O.OS. Statistics were carried out by one-way ANOVA 
with comparisons against the unsupplemented control. 
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5.4 Comparison of 1C Precursor Supplementation Studies 
We compared the baseline plasma formate concentrations between rats fed the 
folate-replete version of each diet, as well as between rats fed the folate-deficient 
version of each diet (Figure 5.21 (a) and (b) respectively). No significant difference 
exists on the basis of diet origin on the folate-replete level. However, rats fed the 
folate-deficient version of the Dyets diet (cat. #5 17777) had plasma formate levels 
significantly lower than rats fed the folate-deficient form of the AIN-93G-based diet. 
The same trend exists when a similar comparison is made for urinary formate 
excretion (normalized to creatinine excretion). Figure 5.22 (a) compares urinary 
formate excretion between rats fed the folate-replete versions of each diet, while (b) 
compares urinary formate excretion between rats fed the folate-deficient version of 
either diet. No significant difference exists between the folate-replete versions. 
However, rats fed the Dyets (cat. #5 17777) folate-deficient diet excrete significantly 
lower quantities of formate compared to rats fed the folate-deficient version of the AIN-
93G-based diet. 
Since the folate-replete versions of each diet resulted in comparable plasma 
formate levels, we compared the folate-replete version of each diet supplemented with 
either histidine or serine with each other (5.23 (a) and (b) respectively). A comparison 
of the plasma formate levels, rather than urinary levels, was practical due to more 
consistent standard deviations in the plasma data (eg. unequal SDs - Figure 5.22 a). 
Histidine was of interest because it produced a plasma formate concentration 
significantly higher than the unsupplemented folate-replete control in both of the 1C 
precursor supplementation studies. Although serine only produced a significant 
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Figure 5.21. The plasma formate concentration of rats fed either an AIN-93G-based 
diet or a Dyets Inc diet (for 18 and 15 days respectively). (a) compares the folate-
replete versions of these diets, and (b) compares the folate-deficient versions of these 
diets. One asterisk indicates a significance of P<0.05 by a two-tailed t-test. 
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Figure 5.22. 24 hour formate excretion, normalized to creatinine excretion, of rats fed 
either an AIN-93G-based diet or a Dyets Inc diet (for 18 and 15 days respectively). (a) 
compares the folate-replete forms of these diets, and (b) compares the folate-deficient 
forms of these diets. One asterisk indicates a significance of P<0.05 by a two-tailed t-
test. 
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Figure 5.23. The plasma formate concentrations of rats fed either an AIN-93G-based 
diet or a Dyets Inc diet (for 18 and 15 days respectively). (a) compares the folate-
replete forms of these diets supplemented with extra serine, and (b) compares the 
folate-replete forms of these diets supplemented with extra histidine. Details of the 
supplementations are provided in Appendices C and D for the AIN-93G-based diet and 
the Dyets diet respectively. No significant differences were found. 
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increase in the formate in the Dyets 1C precursor supplementation study, we noted 
that the baseline AIN-93G has several fold more serine than the baseline Dyets diet, so 
a comparison was deemed worthwhile in this case. Neither of these comparisons 
(serine or histidine) was found to vary significantly on the basis of the diet. 
5.5 Analysis 
Our switch from the Dyets Inc. L-amino acid-defined diet to the AIN-93G-based 
diet necessitated a repetition of the dietary one-carbon precursor supplementation 
experiment. This gave us the opportunity to compare the results of these two 
experiments. 
We noted that plasma formate is significantly increased in both studies among 
folate-replete, histidine-supplemented rats compared to the folate-replete controls. 
Similarly, we note that in both experiments, the plasma formate concentration 
decreased among folate-deficient, glycine supplemented rats compared to the folate-
deficient controls. This decrease in formate may be due to the fact that SHMT is a 
reversible enzyme. An excess of glycine could be used to produce serine, drawing from 
the one-carbon pool in the process. 
Data from the initiallC precursor supplementation study (using Dyets) 
indicated that serine supplementation among folate-replete rats resulted in an increase 
in plasma formate concentration over the folate-replete controls, an observation which 
was mirrored by an increase in urinary formate excretion in this group. This was not 
found in the AIN-93G-based study, a finding we could attribute to the fact that the AIN-
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93G-based diet has 3 times the amount of serine as the base Dyets Inc. #517777 diet 
(as noted in the diet comparison featured in Appendix 8). 
Choline supplementation in the folate-deficient AIN-93G-based diet elevated the 
plasma formate concentration compared to the folate-deficient unsupplemented 
control. This is mirrored in the urinary formate excretion. This suggests that the 
choline catabolism pathway may be a significant source of free formate in these rats. 
Although we note no increase in the plasma formate concentration as a result of 
tryptophan supplementation in rats fed a folate-deficient AIN-93G-based diet (Figure 
5.18), we do see an increase in urinary formate excretion. This may be due to the fact 
that tryptophan has been shown to increase the glomerular filtration rate( 57) which 
may increase the urinary loss of formate. However this does not explain why a similar 
increase informate excretion is missing in folate-replete rats. 
Since we found no difference in hepatic catalase activity between the folate-
replete and folate-deficient rats, we cannot attribute changes in the formate levels to 
catalase. However, it is important to note that this was an in vitro assay of activity, and 
thus not necessarily representative of the activities we would see in a whole rat. 
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Chapter Six- General Conclusions and Future Work 
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6.1 General Conclusions and Future Work 
The work presented in this thesis will serve to increase the understanding of 
formate in the context of one-carbon metabolism. The baseline plasma formate 
concentration, urinary formate excretion and the underlying rate of formate 
production were all shown to change significantly during folate-deficiency. Formate 
could therefore be used as a marker for impaired folate metabolism. With further 
study, it is conceivable that formate could be used as a general marker of impaired one-
carbon metabolism (such as deficiencies in the other 8 vitamins involved in 1C 
metabolism such as 86, 812 or riboflavin, or inborn errors in the various relevant 
enzymes). 
The optimization of the coupled FDH/diaphorase assay was instrumental in the 
work presented in this thesis. A key requirement of any endpoint assay is that, after 
the component reactions have come to completion, the end result should not change 
with time. The persistent rise in absorbance (the "creep") seen in alternate versions of 
this assay meant that it was impossible to determine an absolute formate 
concentration. The use of the PD-10 desalting column for FDH purification paired with 
the INT /diaphorase dye-reduction system resulted in a clean plateau, and a plasma 
formate concentration that could be reported with confidence. This has resulted in a 
robust, economical assay that will allow for the determination of plasma formate 
concentrations in virtually any laboratory setting. The optimizations we have made do 
not require excessive additional resources or time to implement. Additionally, it can be 
adapted to a microplate format as well as a traditional spectrophotometric setup, 
depending on equipment availability. Given that formate metabolism is integral to 1C 
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metabolism in general, plasma formate determination will be useful in many areas of 
this field of research. 
The sodium 13C-formate constant infusion study indicated that formate 
production is a significant fate for some or all of the lC precursors found in the diet. 
35% of the lC precursors ingested in one day gave rise to endogenous formate 
production in folate-replete rats. Moderate folate-deficiency resulted in only 20% of 
the ingested potential dietary lC precursors leading to free formate. After accounting 
for amino acids destined for net protein synthesis, we found that 44% and 24% of 
resulting potential lC precursors were used to produce formate in folate-replete and 
folate-deficient rats respectively. It remains to be seen whether particular precursors 
out of this group of amino acids or choline bear a greater burden in lC production, 
because our infusion experiment was unable to differentiate between formate 
produced from the various folate-associated pathways. The fact that 44% of lC 
precursors are destined to become formate indicates that lC metabolism is a 
significant fate for the 5 amino acids studied (and choline). 
On the basis of our two dietary lC supplementation experiments, we suggest 
that lC production may be a significant fate of choline, histidine and serine. More 
elaborate studies would be necessary to verify this, and subsequently make 
quantifiable statements about the relative importance of particular precursors for 
creating and maintaining the formate pool. Future tracer experiments could use 
labelled-lC precursors of interest to determine which precursors successfully transfer 
significant quantities of 13C into the formate pool. This would confirm or refute the 
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importance of each lC precursor to the health of the lC pool. This could be taken a 
step further by seeing which potentiallC precursors successfully transfer 13( label to 
newly synthesized thymidylate and purine synthesis or into the trans-methylation 
cycle. 
Gaining a more profound and in depth understanding of formate metabolism 
has value beyond a purely fundamental scientific understanding of the metabolic 
pathways involved. In addition to the involvement of folate described in this thesis, 
formate metabolism is dependent on the presence of several other 8 vitamins such as 
riboflavin and 812. Accordingly, there is the potential for formate to act as a biomarker 
for both vitamin deficiencies and impairments in the relevant pathways. The link 
between folate and the provisioning of DNA bases to rapidly dividing cells (such as in 
the development of embryos, or in tumors) has long been a topic of interest. Given the 
close relationship that we have demonstrated not only between folate and formate 
levels, but also between folate levels and the rate of endogenous formate production, 
formate must be considered as an important element in the arena of one-carbon 
metabolism. Further research will help to elucidate the relationship between this 
apparently important pool of free one-carbon units, their incorporation into the folate-
associated one-carbon pool, and the demands on this resource from the body's various 
one-carbon requiring pathways. 
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Appendices 
Appendix A - Plasma formate under a variety of physiological situations. 
Samples from our laboratory, covering a range of common physiological 
conditions in the rat, were assayed to determine the plasma formate concentration 
using the coupled enzymatic assay described in section 2.6.1. These are provided in 
Table Al. 
The low and high protein diets were based on an AIN-93G formula, but with 0, 
20 or 50% casein by mass, respectively. The difference from the normal 20% casein 
was offset proportionally by all carbohydrate sources. The rats were fed for a week on 
this diet. 
Artificial diabetes was induced in rats using streptozotocin (100 mgjkg body 
weight,in saline) to destroy the pancreatic 6-cells responsible for insulin production. 
Diabetic controls were monitored, and given sufficient insulin to maintain the glucose 
concentration inside the normal physiological range. This protocol was continued for 
several days prior to sampling of blood. 
Neonatal pups were removed from their litters and blood was sampled, while 
weanling rats were obtained at -70 g, and blood sampled. 
Fed rats were obtained at 200 g, and fed a chow diet ad libitum for 48 hours and 
blood was sampled. Fasted rats were obtained at 200 g, and received no food for 48 
hours prior to blood being sampled. In both cases, animals had free access to water. 
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Table Al. Plasma formate in the rat in a number of physiological conditions. 
Concentrations were determined by coupled enzyme assay (formate dehydrogenase/ 
diaphorase). Plasma formate concentration is given as the concentration (llM), with the 
standard deviation in parenthesis. 
Physiological Condition 
Low Protein 
Normal Protein 
Diabetic Control 
Diabetic 
Fed 
Fasted 
Plasma formate 
concentration 
69 
77 
60 (7) 
67 (16) 
34 
38 
Sample size 
5 
5 
3 
5 
4 
4 
Note: With the exception of the fed and fasted rats, all animal care work presented in 
this table was carried out by Drs. Simon Lamarre and Robin DaSilva. The assaying of 
plasma for all samples was carried out by the author of this thesis and Mr. Luke 
Macmillan. 
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Appendix B - Comparison of amino acid composition of diets 
Table 81. A comparison of the quantities of amino acids present in two experimental 
diets that can be used to induce folate-deficiency in rats. The central column indicates 
the fold difference for each amino acid. A red bar indicates that a greater quantity is 
present in the Dyets Inc. (FD- #517777, FR- #5 17802) amino acid-defined diet, and is 
the composition reported form Dyets Inc .. A blue bar indicates that there is a greater 
quantity in the AIN-93G -based diet (casein-based), and is the typical casein amino acid 
profile, as reported in the AIN-93 Diet Report. 
Fold Difference 
g AA/kg diet 
11.2 
His 3.3 
Asn 6.82 
Lys 18 
Tyr 3.5 
Trp 1.74 
Phe 11.6 
Met 8.2 
Cys 3.5 
Thr 8.2 
Leu 11.1 
lie 8.2 
Val 8.2 
Gly 23.3 
Pro 3.5 
Glu 35 
Ala 3.5 
Asp 3.5 
Ser 3.5 
Gin 
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-1.8 
1. 
1. 
-1.3 
-1.8 
1.1 
-1.2 
1.4 
1.0 
1.2 
Arg 
His 
Asn 
Lys 
Tyr 
Trp 
Phe 
Met 
Cys 
Thr 
Leu 
lie 
Val 
Gly 
Pro 
Glu 
Ala 
Asp 
Ser 
Gin 
6.4 
4.6 
13 
9.3 
2.1 
8.8 
4.6 
3.7 
6.7 
15.4 
8.5 
10 
3.2 
20.5 
36.3 
4.6 
12.2 
9.7 
Appendix C - Experimental diets (compositions, mineral mixes, and vitamin 
mixes) 
Table Cl. List of ingredients for Dyets Inc. folate deficient L-amina acid-defined diet 
(Cat. #517777). The full amino acid profile is found in Appendix B. 
Ingredient gfkg 
Total L-amina acids 176 
Dextrin 397 
Cellulose (microcrystalline) 50 
Sucrose 197 
Sodium acetate 8 
Corn oil (g) 100 
Choline chloride 2 
Succinyl sulfathiazole 10 
Mineral mix #210020 50 
Vitamin mix #317759 (folic acid free) 10 
Table C2. List of ingredients for production of AIN-93G-based diet 
Ingredient g/kg diet 
Cornstarch 387.5 
High-nitrogen casein 200 
Dextrinized cornstarch 132 
Sucrose 100 
Soybean oil (g) 70 
Fiber 50 
Mineral mix (AIN-93G-MX) 35 
Vitamin mix (AIN-93-VX) 10 
Succinyl sulfathiazole 10 
L-Cystine 3 
Choline bitartrate 2.5 
Tert-butylhydroquinone 0.014 
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Table C3. Mineral mix #210020- Elements provided to 1 kg Dyets diet from 50g of 
mineral mix 
Ingredient gjkg 
Calcium carbonate 14.6 
Calcium phosphate, dibasic 0.17 
Sodium chloride 12.4 
Potassium phosphate, dibasic 17.2 
Magnesium sulfate, anhydrous 2.45 
Manganese sulfate, monohydrate 0.18 
Ferric citrate, U.S.P. 0.63 
Zinc carbonate, basic 0.058 
Cupric carbonate, basic 0.054 
Potassium iodide (mg) 0.250 
Sodium selenite(mg) 0.495 
Molybdic acid, ammonium salt (mg) 1.25 
Chromium potassium sulfate, 19 
dodecahydrate ( mg) 
Sodium fluoride (mg) 2.5 
Sucrose, finely powdered 2.09 
Table C4. Vitamin mix #317759- Vitamins provided to 1 kg Dyets diet from lOg of 
vitamin mix 
Ingredient mgjkg 
Thiamin HCl 6 
Riboflavin 6 
Pyridoxine HCl 7 
Nicotinic acid 0.3 
Calcium pantothenate 16 
Folic Acid 0 
Biotin 0.2 
Vitamin 812 (0.1 %) 50 
Vitamin A palmitate (500,000 IU/g) 8 
Vitamin 03 (400,000 IU/g) 2.5 
Vitamin E acetate (500 IU/g) 100 
Menadione sodium bisulfite 50 
A corresponding folate-replete diet was used for control purposes (Dyets Inc. Cat. # 
517802), containing an identical vitamin mix supplemented by folic acid at a strength 
of 2 mg per kg complete diet. The balance of the lOg is made up of sucrose. 
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Table C5. Mineral mix (AIN-93G-MX)- Elements provided to 1 kg Dyets diet from 35g 
of mineral mix 
diet 
1 
1561 0.2 
3600 0.15 
1019 1 
1571 0.5 
300 m 0.15 
507 5 
35 0.5 
6 0.1 
nese 10 0.1 
Zinc 30 
Table C6. Vitamin mix (AIN-93-VX) - Vitamins provided to 1 kg Dyets diet from lOg of 
vitamin mix 
Ingredient Unit/kg diet Quantity 
Thiamin HCl mg 6 
Riboflavin mg 6 
Pyridoxine HCl mg 7 
Niacin mg 30 
Calcium Pantothenate mg 16 
Folic Acid mg 2 
Biotin mg 0.2 
Cyanocobalamin (812, 0.1 %) mg 25 
Vitamin A Palmitate IU 4000 
Vitamin E Acetate IU 75 
Vitamin 03 IU 1000 
Vitamin Kl mg 0.75 
A corresponding folate-deficient AIN-93G-based diet was produced containing a similar 
vitamin mix, but lacking folic acid. 
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Figure Cl. Folic acid content of the folate-replete (cat. #517802) and folate-deficient 
(cat. #517777) versions of the Dyets Inc. diet which are advertised as containing 2 mg 
and 0 mg of folic acid per kg of diet respectively. The values are given are the mean; 
error bars are standard deviation (n=6 for folate-replete, n=9 for folate-deficient). 
These measurements were performed by Dr. MacFarlane of Health Canada, based on a 
microbiological assay using L. Casei ( 42). Although the folate-replete diet yielded less 
folate than expected ( -1.3 mgjkg diet instead of 2 mg/kg diet), the folate-deficient diet 
was almost completely free of folate contamination as required. 
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Appendix D - Dyets Inc. amino acid-defined diet (cat. #517777, #517802) 1C 
precursor supplementation trial diet modifications 
Table 01. Molar quantity of lC precursor added to lkg of supplemented diet 
Molar quantity of lC Molar quantity of 
precursor added to 1 kg diet L-alanine added to 
Amino Acid (mmol) lkg diet ( mmol) 
Glycine 310 0 
L-Histidine 21 289 
L-Tryptophan 9 301 
L-Methionine 55 255 
L-Alanine 310 0 
L-Serine 33 277 
Sarcosine 55 255 
Oimethylglycine 55 255 
Choline chloride 55 255 
Table 02. Masses of lC precursor and alanine added to lkg of supplemented diet 
Mass of lC precursor Mass of L-alanine 
Amino Acid added to 1 kg diet(g) added to lkg diet (g) 
Glycine 23.25 0 
L-Histidine 3.31 25.69 
L-Tryptophan 1.71 26.78 
L-Methionine 8.19 22.69 
L-Alanine 27.59 0 
L-Serine 3.5 24.63 
Sarcosine 4.91 22.69 
Oimethylglycine 5.56 22.69 
Choline chloride 7.65 22.69 
Oyets Inc. ships the amino acid-defined diet pre-mixed, so it is not possible to 
offset the lC precursor and alanine supplementation by reducing other specific 
ingredients. When adding supplementations to these diets, the particular precursor 
and alanine were added to enough premixed diet to make up one kilogram. This meant 
that in the supplemented diets, all ingredients (from Table Bl) were actually present in 
slightly lower quantities than the control (unsupplemented) diets. Since the combined 
masses of the supplemented lC precursor/alanine never exceeded lOg (into - 990g of 
premixed diet), there was a - 1% variance between control and supplemented diets for 
the other ingredients. 
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Appendix E- AIN-93G-based 1C precursor supplementation trial diet 
modifications 
Table El. Quantity of 1C precursor added to 1kg of supplemented diet 
1C Precursor Molar quantity of 1C Molar Mass Mass of 1C 
precursor added to 1 kg precursor added to 
diet (mmol) 1 kg diet( g) 
Serine 46 105 4.8 
Tryptophan 46 204 9.4 
Glycine 46 75 3.5 
Alanine 46 89 4.1 
Choline bitartrate 46 253 11.6 
Histidine 46 155 7.1 
Methionine 46 149 6.9 
The AIN-93G-based diets are mixed in-house, allowing for the increase or decrease of 
specific ingredients as necessary. Accordingly, when supplementing the special 
experimental diets (as per the final column of Table Dl), the quantity of corn starch 
was reduced correspondingly. As a result, with the exception of corn starch and the 
supplemented 1C precursor in question, the quantities of individual ingredients did not 
vary between the control diets and the supplemented diets. 
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